
(
  (S
    (NP (JJ Cellular) (NN Notch) (NN responsiveness))
    (VP (VBZ is)
      (VP (VBN defined)
        (PP (IN by)
          (NP (JJ phosphoinositide) (JJ 3-kinase-dependent) (NNS signals)))))))

(
  (S
    (NP (NN Abstract))))

(
  (S
    (NP
      (NP (NN Background))
      (: :)
      (S
        (NP (NN Notch))
        (VP (VBZ plays)
          (NP (DT a) (JJ wide-ranging) (NN role))
          (PP (IN in)
            (S
              (VP (VBG controlling)
                (NP
                  (NP (NN cell) (NN fate))
                  (, ,)
                  (NP (NN differentiation))
                  (CC and)
                  (NP (NN development))))))))
      (. .))))

(
  (S
    (S
      (NP (DT The) (NN PI3K-Akt) (NN pathway))
      (VP (VBZ is)
        (NP
          (NP (DT a)
            (ADJP (RB similarly) (VBN conserved))
            (NN signalling) (NN pathway))
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBZ regulates)
                (NP
                  (NP (NNS processes))
                  (PP (JJ such) (IN as)
                    (NP
                      (NP (NN differentiation))
                      (, ,)
                      (NP (NN proliferation))
                      (CC and)
                      (NP (NN survival)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Mice))
        (PP (IN with)
          (NP (VBN disrupted) (NN Notch)
            (CC and)
            (NN PI3K) (NN signalling))))
      (VP (VBP show)
        (NP (JJ phenotypic) (NNS similarities))
        (PP (IN during)
          (NP (JJ haematopoietic) (NN cell) (NN development)))
        (, ,)
        (S
          (VP (VBG suggesting)
            (NP
              (NP (JJ functional) (NN interaction))
              (PP (IN between)
                (NP (DT these) (NNS pathways))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Results))
      (: :)
      (S
        (NP (PRP We))
        (VP (VBP show)
          (SBAR (IN that)
            (S
              (NP
                (NP (JJ cellular) (NN responsiveness))
                (PP (TO to)
                  (NP (NN Notch) (NNS signals))))
              (VP (VBZ depends)
                (PP (IN on)
                  (NP
                    (NP (DT the) (NN activity))
                    (PP (IN of)
                      (NP (DT the) (NN PI3K-Akt) (NN pathway)))
                    (PP (IN in)
                      (NP
                        (NP (NNS cells))
                        (ADJP (RB as) (JJ diverse)
                          (PP (IN as)
                            (NP
                              (NP (NN CHO) (NNS cells))
                              (, ,)
                              (NP (JJ primary) (NNS T-cells))
                              (CC and)
                              (NP (JJ hippocampal) (NNS neurons))))))))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NN Induction))
        (PP (IN of)
          (NP (DT the) (JJ endogenous) (NN PI3K-Akt) (NN pathway)))
        (PP
          (PP (IN in)
            (NP
              (NP (NN CHO) (NNS cells))
              (PRN (-LRB- -LRB-)
                (PP (IN by)
                  (NP (DT the) (NN insulin) (NN pathway)))
                (-RRB- -RRB-))))
          (, ,)
          (PP (IN in)
            (NP
              (NP (NNS T-cells))
              (PRN (-LRB- -LRB-)
                (PP (IN via)
                  (NP (NN TCR) (NN activation)))
                (-RRB- -RRB-))))
          (CC or)
          (PP (IN in)
            (NP
              (NP (NNS neurons))
              (PRN (-LRB- -LRB-)
                (PP (IN via)
                  (NP (NN TrKB) (NN activation)))
                (-RRB- -RRB-))))))
      (VP (VBZ potentiates)
        (NP (NN Notch-dependent) (NNS responses))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP propose)
        (SBAR (IN that)
          (S
            (NP (DT the) (NN PI3K-Akt) (NN pathway))
            (VP (VBZ exerts)
              (NP
                (NP (PRP$ its) (NN influence))
                (PP (IN on)
                  (NP (NN Notch))))
              (ADVP (RB primarily))
              (PP (IN via)
                (NP
                  (NP (NN inhibition))
                  (PP (IN of)
                    (NP
                      (NP (NN GSK3-beta))
                      (, ,)
                      (NP
                        (NP (DT a) (NN kinase))
                        (VP (VBN known)
                          (S
                            (VP (TO to)
                              (VP
                                (VP (VB phosphorylate))
                                (CC and)
                                (VP (VB regulate)
                                  (NP (NN Notch) (NNS signals)))))))))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Conclusion))
      (: :)
      (S
        (NP (DT The) (NN PI3K-Akt) (NN pathway))
        (VP (VBZ acts)
          (PP (IN as)
            (NP
              (NP (DT a) (`` ``) (NN gain) (NN control) (NN ''))
              (PP (IN for)
                (NP (NN Notch) (NN signal) (NNS responses)))))))
      (. .))))

(
  (S
    (S
      (SBAR (IN Since)
        (S
          (NP
            (NP (JJ physiological) (NNS levels))
            (PP (IN of)
              (NP (JJ intracellular) (NN Notch))))
          (VP (VBP are)
            (ADVP (RB often))
            (ADJP (JJ low)))))
      (, ,)
      (NP
        (NP (NN coincidence))
        (PP (IN with)
          (NP (NN PI3K-activation))))
      (VP (MD may)
        (VP (VB be)
          (ADJP (JJ crucial)
            (PP (IN for)
              (NP
                (NP (NN induction))
                (PP (IN of)
                  (NP (NN Notch-dependent) (NNS responses)))))))))
    (. .)))

(
  (S
    (NP (NN Background))))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS phosphoinositide-3-kinases))
        (PRN (-LRB- -LRB-)
          (NP (NNS PI3Ks))
          (-RRB- -RRB-)))
      (VP (VBP constitute)
        (NP
          (NP (DT an) (NN enzyme) (NN family))
          (PP (IN of)
            (NP (NN p85/p110) (NNS heterodimers)))
          (ADJP (JJ responsible)
            (PP (IN for)
              (S
                (VP (VBG regulating)
                  (NP (JJ numerous) (JJ biological) (NNS processes))
                  (PP (IN in)
                    (NP
                      (NP (JJ diverse) (NN cell) (NNS types))
                      (ADJP (NN -LSB-1) (-RRB- -RSB-) (JJ such)
                        (PP (IN as)
                          (NP
                            (NP (JJ cellular) (NN proliferation))
                            (, ,)
                            (NP (NN differentiation))
                            (CC and)
                            (NP (NN survival))))))))))))))
    (. .)))

(
  (S
    (SINV
      (PP (IN Of)
        (NP (JJ particular) (NN interest)))
      (VP (VBZ is)
        (NP
          (NP (DT the) (NN role))
          (PP (IN of)
            (NP (DT this) (NN pathway)))
          (PP (IN in)
            (NP (NN lymphocyte) (NN activation))))
        (PRN (, ,)
          (SBAR
            (WHADVP (WRB where))
            (S
              (NP
                (NP (NN antigen))
                (CC and)
                (NP (NN cytokine) (NN receptor) (NN ligation)))
              (VP (VBP result)
                (PP (IN in)
                  (NP
                    (NP (NN activation))
                    (PP (IN of)
                      (NP (CD PI3K-driven) (NNS signals) (NN -LSB-2))))))))
          (-RRB- -RSB-)))
      (. .))))

(
  (S
    (S
      (NP
        (NP (DT A) (JJ key) (NN target))
        (PP (IN of)
          (NP (NN PI3K) (NN activity))))
      (VP (VBZ is)
        (NP
          (NP (NN Akt/PKB))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBZ mediates)
                (NP
                  (NP (JJ many))
                  (PP (IN of)
                    (NP
                      (NP (DT the) (NNS effects))
                      (PP (IN of)
                        (NP (NN PI3K) (NN activation) (CD -LSB-3)))))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (NN PI3K))
      (VP (VBZ is)
        (VP (VBN activated)
          (PP
            (PP (IN in)
              (NP (NNS T-cells)))
            (CC both)
            (PP (IN in)
              (NP
                (NP (NN response))
                (PP (TO to)
                  (NP
                    (NP
                      (NP (NN T-cell) (NN receptor))
                      (PRN (-LRB- -LRB-)
                        (NP (NN TCR))
                        (-RRB- -RRB-)))
                    (NN stimulation)))))
            (, ,)
            (CC and)
            (PP (IN by)
              (NP
                (NP (NN engagement))
                (PP (IN of)
                  (NP (DT the) (JJ co-stimulatory) (NN receptor) (NN CD28)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Gene) (NN targeting) (NNS studies))
      (VP (VBP have)
        (VP (VBN emphasised)
          (NP (DT the) (JJ essential) (NN role)
            (S
              (NP (NN PI3K))
              (VP (VBZ plays)
                (PP (IN in)
                  (NP (DT these) (NNS responses)))))))))
    (: :)
    (S
      (SBAR (IN whereas)
        (S
          (NP (JJ PI3K-deficient) (NNS mice))
          (VP (VBP are)
            (NP (JJ immunodeficient) (NN -LSB-4,5)))
          (-RRB- -RSB-)))
      (, ,)
      (NP (JJ constitutive) (NN activity))
      (VP (VBZ is)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (JJ hyperproliferative) (NN T-cell) (NNS responses))
              (CC and)
              (NP (NN autoimmunity) (CD -LSB-6) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (ADVP (RB Equally))
    (, ,)
    (S
      (VP (VBG preventing)
        (NP
          (NP (DT the) (NN termination))
          (PP (IN of)
            (NP (NN PI3K) (NN activity))))
        (PP (IN by)
          (NP
            (NP (JJ conditional) (NN gene) (NN targeting))
            (PP (IN of)
              (NP
                (NP (DT the) (NN lipid) (NN phosphatase) (NN Pten))
                (PP (IN in)
                  (NP (NNS T-cells)))))))))
    (VP (VBZ leads)
      (PP (TO to)
        (NP
          (NP
            (NP (NN autoimmunity))
            (CC and)
            (NP (NN development)))
          (PP (IN of)
            (NP (NN lymphoma) (NN -LSB-7) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS studies))
      (VP (VBP demonstrate)
        (SBAR (IN that)
          (S
            (NP (NN PI3K) (NN activity))
            (VP
              (VP (VBZ is)
                (ADVP (RB tightly))
                (VP (VBN regulated)))
              (CC and)
              (VP (VBZ plays)
                (NP (DT an) (JJ integral) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN maintenance))
                    (PP (IN of)
                      (NP (NN lymphocyte) (NN homeostasis)))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN Notch) (NN signalling) (NN pathway))
      (VP (VBZ plays)
        (NP (DT a) (JJ critical) (NN role))
        (PP (IN in)
          (NP
            (NP (DT a) (JJ wide) (NN range))
            (PP (IN of)
              (NP
                (NP (JJ developmental) (NNS processes))
                (PP (IN in)
                  (NP (DT the) (NN embryo)))
                (, ,)
                (PP (VBG including)
                  (NP
                    (NP (JJ binary) (NN lineage) (NNS decisions))
                    (CC and)
                    (NP (NN boundary) (NN formation) (CD -LSB-8)))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (NP
      (NP (NN Binding))
      (PP (IN of)
        (NP (DT the) (NN Notch) (NNS ligands)
          (NP
            (NP (NN Delta))
            (CC or)
            (NP (NN Jagged)))))
      (PP (TO to)
        (NP (DT the) (NN Notch) (NN receptor))))
    (VP (VBZ instigates)
      (NP
        (NP (JJ proteolytic) (NN cleavage))
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBZ releases)
              (NP
                (NP
                  (NP (DT the) (NN Notch) (JJ intracellular) (NN domain))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP N-IC) (-RRB- -RRB-) (CD -LSB-8))
                    (-RRB- -RSB-)))
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (VBZ activates)
                      (NP
                        (NP (DT the) (NN transcription) (NN factor) (NN CBF-1))
                        (SBAR
                          (WHNP (WDT which))
                          (S (, ,)
                            (PP (IN in)
                              (NP (NN turn)))
                            (, ,)
                            (VP (VBZ controls)
                              (NP
                                (NP (NN target) (NNS genes))
                                (PP (JJ such) (IN as)
                                  (NP (NN Hes-1) (NN -LSB-9)))))
                            (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Central))
        (PP (TO to)
          (NP
            (NP (NN Notch) (POS 's))
            (NN role))))
      (VP (VBZ is)
        (NP (PRP$ its) (NN ability)
          (S
            (VP (TO to)
              (VP (VB modulate)
                (NP
                  (NP (DT the) (JJ differentiative) (NN potential))
                  (PP (IN of)
                    (NP (JJ pluripotent) (NNS cells))))))))
        (, ,)
        (PP (IN for)
          (NP (NN instance)))
        (PP (IN in)
          (NP (DT the) (JJ neural) (NN stem) (NN cell) (NN compartment)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS effects))
        (PP (IN of)
          (NP (NN Notch))))
      (ADVP (RB also))
      (VP (VBP extend)
        (PP (TO to)
          (NP
            (NP (DT the) (VBG developing) (JJ immune) (NN system))
            (, ,)
            (SBAR
              (WHADVP (WRB where))
              (S
                (NP (PRP it))
                (VP (VBZ directs)
                  (NP
                    (NP (DT the) (NN differentiation))
                    (PP (IN of)
                      (NP (JJ lymphoid) (NNS precursors)
                        (NP (CD -LSB-10))))))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Recent) (NNS data))
      (VP (VBP have)
        (VP (VBN highlighted)
          (NP
            (NP (JJ unexpected) (NNS functions))
            (PP (IN for)
              (NP (DT the) (NN Notch) (NN pathway))))
          (PP (IN in)
            (S
              (VP (VBG regulating)
                (NP
                  (NP (NNS cells))
                  (PP (IN of)
                    (NP (DT the) (JJ peripheral) (JJ immune) (NN system))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Co-incident) (NN delivery))
        (PP (IN of)
          (NP (NN Notch) (NNS signals)))
        (PP (TO to)
          (NP (NNS T-cells))))
      (VP (VBZ exerts)
        (NP (DT a) (JJ profound) (NN effect))
        (PP (IN upon)
          (NP
            (NP (DT the) (NN outcome))
            (PP (IN of)
              (NP
                (NP (NN antigen-stimulation)
                  (ADJP (FW in) (FW vitro))
                  (NN -LSB-11-13) (-RRB- -RSB-))
                (VP (VBG suggesting)
                  (SBAR (IN that)
                    (S
                      (NP
                        (NP
                          (NP (NN interplay))
                          (PP (IN between)
                            (NP (DT the) (NN antigen) (NN receptor))))
                        (CC and)
                        (NP (NN Notch) (NNS pathways)))
                      (VP (VBP regulate)
                        (NP
                          (NP (DT the) (NN outcome))
                          (PP (IN of)
                            (NP (JJ peripheral) (NN T-cell) (NNS responses))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Mice))
        (VP (VBG expressing)
          (NP
            (NP
              (ADJP (RB catalytically) (JJ inactive))
              (NN PI3K) (NN subunit) (NN p110δ) (CD -LSB-5) (-RRB- -RSB-))
            (CC or)
            (NP
              (NP (DT a) (NN deletion))
              (PP (IN of)
                (NP (NN p110δ) (NN -LSB-4))))
            (-RRB- -RSB-))))
      (VP (VBP exhibit)
        (NP (JJ defective)
          (NP
            (NP (NN B-cell))
            (CC and)
            (NP (NN T-cell)))
          (NN receptor) (NN signalling))))
    (: :)
    (S
      (S
        (NP
          (NP (JJ antigen-mediated) (NN activation))
          (PP (IN of)
            (NP
              (NP (NN BCR))
              (CC or)
              (NP (NN TCR)))))
        (VP (VBZ fails)
          (S
            (VP (TO to)
              (VP (VB activate)
                (NP (NN Akt)))))))
      (CC and)
      (S
        (NP (NNS cells))
        (VP (VBP exhibit)
          (NP
            (NP (JJ defective) (NN proliferation))
            (CC and)
            (NP (NN cytokine) (NNS responses))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Recent) (NNS publications))
      (VP (VBP have)
        (VP (VBN demonstrated)
          (SBAR (IN that)
            (S
              (NP (NN Notch) (NNS signals))
              (VP (VBP modulate)
                (NP (NN cytokine) (NN production))
                (PP (IN by)
                  (NP (NNS T-cells) (CD -LSB-12,13) (-RRB- -RSB-)))
                (, ,)
                (S
                  (VP (VBG suggesting)
                    (SBAR (IN that)
                      (S
                        (NP (DT the) (NN Notch) (NN pathway))
                        (VP (VBZ integrates)
                          (PP (IN with)
                            (NP (JJ TCR-mediated) (NNS signals)))
                          (S
                            (VP (TO to)
                              (VP (VB modulate)
                                (NP (NN cytokine) (NN production))))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (JJ marginal) (NN zone) (NN B) (-LRB- -LRB-) (NN MZB) (-RRB- -RRB-) (NN cell) (NN development))
      (VP (VBZ is)
        (ADJP (RB severely) (JJ impaired)
          (PP (IN in)
            (NP
              (UCP (CC both)
                (NP (NN p110δ-))
                (CC and)
                (ADJP (JJ Notch2-deficient)))
              (NNS mice) (CD -LSB-4,14) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBN Taken)
          (ADVP (RB together))
          (PP (IN with)
            (NP (NN Notch) (POS 's) (NN ability)
              (S
                (VP (TO to)
                  (VP (VB modulate)
                    (NP (NN TCR) (NNS signals)))))))))
      (, ,)
      (NP (DT this) (JJ phenotypic) (NN similarity))
      (VP (VBD suggested)
        (PP (TO to)
          (NP (PRP us)))
        (NP
          (NP (DT the) (NN possibility))
          (PP (IN of)
            (NP (NN Notch/PI3K) (NN signalling) (NN integration))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS studies))
      (VP (VBP reveal)
        (SBAR (IN that)
          (S
            (NP (DT the) (NN PI3K-Akt) (NN pathway))
            (VP (VBZ is)
              (NP
                (NP (DT a) (JJ potent) (NN inducer))
                (PP (IN of)
                  (NP (NN Notch-dependent) (NNS responses))))
              (PP (IN in)
                (NP
                  (NP (NN cell) (NNS types))
                  (PP (IN as)
                    (NP
                      (NP (JJ diverse) (NNS T-cells))
                      (CC and)
                      (NP (NNS neurons))))))
              (, ,)
              (S
                (VP (VBG demonstrating)
                  (SBAR (IN that)
                    (S
                      (NP (DT this))
                      (VP (VBZ is)
                        (NP
                          (NP (DT a) (NN cell) (NN signalling) (NN paradigm))
                          (PP (IN with)
                            (NP (JJ broad) (NN applicability))))))))))))))
    (. .)))

(
  (S
    (NP (NNS Results))))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB address)
            (SBAR (IN whether)
              (S
                (NP (DT the) (NN PI3K) (NN pathway))
                (VP (VBZ is)
                  (NP
                    (NP (DT a) (NN regulator))
                    (PP (IN of)
                      (NP (NN Notch-responsiveness))))))))))
      (, ,)
      (NP (PRP we))
      (VP (VBD generated)
        (NP
          (NP (DT a) (NN Jurkat) (NN E6.1) (NN T-cell) (NN line))
          (SBAR
            (WHNP (WDT which))
            (S
              (ADVP (RB stably))
              (VP (VBZ expresses)
                (NP
                  (NP (JJ full-length) (JJ human) (NN Notch2) (NN cDNA))
                  (PRN (-LRB- -LRB-)
                    (NP (NN J-N2) (NNS cells))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN J-N2) (NNS cells))
        (VP (VBD were)
          (VP (VBN treated)
            (PP (IN with)
              (NP (JJ plate-bound)
                (NP
                  (NP (JJ recombinant) (JJ human) (NN Delta1) (NN protein))
                  (PRN (-LRB- -LRB-)
                    (ADVP (RB hereafter))
                    (VP (VBN referred)
                      (PP (TO to))
                      (PP (IN as)
                        (NP (NN Delta1-Fc))))
                    (-RRB- -RRB-)))
                (NN fusion) (NN protein))))))
      (, ,)
      (CC and)
      (S
        (NP (NN Notch) (NN signalling))
        (VP (VBD was)
          (VP (VBN measured)
            (S
              (VP (VBG using)
                (NP
                  (NP (DT a) (JJ transiently-transfected) (JJ CBF1-driven) (NN luciferase) (NN reporter) (NN construct))
                  (PRN (-LRB- -LRB-)
                    (NP (NN p10xCBF1-luc))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Plate-bound) (JJ recombinant) (NN Delta1-Fc))
      (ADVP (RB efficiently))
      (VP (VBD transactivated)
        (NP
          (NP (NN CBF1-luc))
          (, ,)
          (VP (VBG driving)
            (PP (IN around)
              (NP
                (NP (DT a) (JJ 10-fold) (NN increase))
                (PP (IN in)
                  (NP
                    (NP (NN activity))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Fig.) (NN 1A))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT A) (JJ similar) (NN result))
      (VP (VBD was)
        (VP (VBN obtained)
          (S
            (VP (VBG using)
              (NP
                (NP (DT the) (JJ murine) (NN Hes-1) (NN promoter))
                (VP (VBN cloned)
                  (ADVP (RB upstream)
                    (PP (IN of)
                      (NP (DT the) (NN luciferase) (NN reporter))))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNS data))
                      (VP
                        (ADVP (RB not))
                        (VBN shown)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Strikingly))
      (, ,)
      (NP
        (NP (NN treatment))
        (PP (IN of)
          (NP (DT these) (NNS cells)))
        (PP (IN with)
          (NP (DT the) (NN PI3K) (NN inhibitor) (NN LY294002))))
      (VP (VBD led)
        (PP (TO to)
          (NP
            (NP (DT a) (JJ dose-dependent) (NN decrease))
            (PP (IN in)
              (NP
                (NP (JJ Delta1-Fc-induced) (NN Notch) (NN signalling))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Fig.) (NN 1A))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (DT A) (JJ similar) (NN result))
      (VP (VBD was)
        (VP (VBN observed)
          (PP (IN with)
            (NP
              (NP (DT the) (JJ mechanistically-distinct) (NN PI3K) (NN inhibitor) (NN Wortmannin))
              (PRN (-LRB- -LRB-)
                (S
                  (NP (NNS data))
                  (VP (RB not) (VBN shown)))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN integrity))
        (PP (IN of)
          (NP (DT this) (NN reporter) (NN assay)))
        (PP (IN as)
          (NP
            (NP (DT an) (JJ accurate) (NN reflection))
            (PP (IN of)
              (NP (NN Notch) (NN signalling))))))
      (VP (VBD was)
        (VP (VBN confirmed)
          (PP (IN by)
            (S
              (VP (VBG assessing)
                (NP
                  (NP (NN mRNA) (NNS levels))
                  (PP (IN of)
                    (NP (DT the) (NN Notch) (NN target) (NN gene) (NN Hes-1))))
                (PP (IN by)
                  (NP
                    (NP (NN Q-PCR))
                    (PP (IN in)
                      (NP
                        (NP (JJ Delta1-Fc-treated) (NN J-N2) (NNS cells))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP Fig.) (NN 1B))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN As)
        (PP (IN with)
          (NP (DT the) (JJ CBF1-dependent) (NN reporter))))
      (, ,)
      (NP
        (NP (NN treatment))
        (PP (IN with)
          (NP (NN LY294002))))
      (VP (VBD inhibited)
        (NP
          (NP (DT the) (NN up-regulation))
          (PP (IN of)
            (NP (NN Hes-1)))
          (PP (IN by)
            (NP (NN Delta1-Fc))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN lipid) (NN phosphatase) (NN Pten))
      (VP
        (VP (VBZ dephosphorylates)
          (NP
            (NP (DT the) (CD 3) ('' ') (NN phosphoinositide) (NNS products))
            (PP (IN of)
              (NP (NN PI3K) (NN catalysis)))))
        (CC and)
        (VP (VBZ prevents)
          (NP
            (NP (JJ downstream) (NN PI3K) (NN signaling))
            (NN -LSB-1) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (NN Jurkat) (NN E6.1) (NNS cells))
      (VP
        (VP (VBP are)
          (ADJP (JJ deficient)
            (PP (IN in)
              (NP
                (NP (NN expression))
                (PP (IN of)
                  (NP (NN Pten)))))))
        (, ,)
        (CC and)
        (ADVP (RB therefore))
        (VP (VBP have)
          (NP (DT a)
            (ADJP (RB highly) (JJ active))
            (NN PI3K-Akt) (NN pathway) (CD -LSB-15))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB therefore))
      (VP (VBN hypothesised)
        (SBAR (IN that)
          (S
            (S
              (VP (VBG reconstituting)
                (NP (DT this) (NN enzyme))))
            (VP (MD would)
              (VP (VB reduce)
                (NP (NN Notch) (NN signalling))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Transient) (NN expression))
        (PP (IN of)
          (NP (NN Pten)))
        (PP (IN in)
          (NP (NN J-N2) (NNS cells))))
      (VP (VBD led)
        (PP (TO to)
          (NP
            (NP (DT a) (NN decrease))
            (PP (IN in)
              (NP
                (NP
                  (ADJP (CC both)
                    (ADJP (JJ basal))
                    (CC and)
                    (ADJP (NN Notch) (JJ ligand-induced)))
                  (NN activation))
                (PP (IN of)
                  (NP
                    (NP (JJ CBF1-dependent) (NN gene) (NN expression))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Fig.) (NN 1C))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (ADJP (JJ Pten-transfected)))
        (CC and)
        (NP
          (ADJP (JJ control)))
        (NP (NNS cells)))
      (VP (VBD showed)
        (NP (JJ equivalent) (NN CBF1-reporter) (NN activity))
        (PP (IN in)
          (NP
            (NP (DT the) (NN presence))
            (PP (IN of)
              (NP (NN LY294002)))))
        (, ,)
        (S
          (VP (VBG demonstrating)
            (SBAR (IN that)
              (S
                (SBAR (IN once)
                  (S
                    (NP (NN PI3K) (NN activity))
                    (VP (VBZ is)
                      (VP (VBN abolished)
                        (ADVP (RB pharmacologically))))))
                (, ,)
                (NP (NN Pten) (NN over-expression))
                (VP (VBZ becomes)
                  (ADJP (JJ redundant)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN PI3K) (NN pathway))
      (VP (VBZ activates)
        (NP
          (NP (JJ several) (NNS enzymes))
          (, ,)
          (PP (VBG including)
            (NP (DT the) (JJ central) (NN signalling) (NN molecule) (NN Akt/PKB))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (ADVP (RB further))
          (VP (VB define)
            (NP
              (NP (DT the) (NN mechanism))
              (SBAR
                (WHPP (IN by)
                  (WHNP (WDT which)))
                (S
                  (NP (NN PI3K) (NN activity))
                  (VP (VBZ regulates)
                    (NP (NN Notch) (NNS signals)))))))))
      (, ,)
      (NP (PRP we))
      (VP (VBD asked)
        (SBAR (IN whether)
          (S
            (NP
              (NP (DT the) (JJ inhibitory) (NN effect))
              (PP (IN of)
                (NP (NN LY294002))))
            (VP (MD could)
              (VP (VB be)
                (VP (VBN recapitulated)
                  (PP (IN with)
                    (NP
                      (NP (DT an) (NN inhibitor))
                      (PP (IN of)
                        (NP (NN Akt))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBG Blocking)
          (NP
            (NP (NN Akt) (NN activity))
            (PP (IN in)
              (NP (NN J-N2) (NNS cells))))
          (PP (IN with)
            (NP (DT the) (JJ selective) (NN inhibitor)))))
      (NP (NN SH-6) (CD -LSB-16) (-RRB- -RSB-))
      (VP (VBD inhibited)
        (NP
          (NP (JJ Delta1-Fc-mediated) (NN upregulation))
          (PP (IN of)
            (NP
              (NP (NN Notch) (NN signalling))
              (PRN (-LRB- -LRB-)
                (NP (NNP Fig.) (CD 1D))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBN Taken)
          (ADVP (RB together))))
      (, ,)
      (NP (DT these) (NNS data))
      (VP (VBP identify)
        (NP (DT the) (NN PI3K-Akt) (NN pathway))
        (PP (IN as)
          (S
            (VP (VBG being)
              (ADJP (JJ responsible)
                (PP (IN for)
                  (NP
                    (NP (DT the) (JJ high) (NN level))
                    (PP (IN of)
                      (NP
                        (NP (JJ ligand-induced) (NN Notch) (NN activation))
                        (PP (IN in)
                          (NP (NN J-N2) (NNS cells)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB next))
      (VP (VBD investigated)
        (SBAR (IN whether)
          (S
            (NP (NN PI3K) (NN activity))
            (ADVP (RB also))
            (VP (VBZ regulates)
              (NP
                (NP (NN Notch-responsiveness))
                (PP (IN in)
                  (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD asked)
        (SBAR (IN whether)
          (S
            (NP
              (NP (NN PI3K) (NN induction))
              (, ,)
              (VP (VBN triggered)
                (PP (IN by)
                  (NP (NN TCR) (NN activation))))
              (, ,))
            (VP (MD could)
              (VP (VB influence)
                (NP
                  (NP (NN Hes-1) (NNS levels))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Fig.) (NN 2A))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (PP (IN In) (DT the) (NN absence) (IN of)
      (NP
        (NP (DT any)
          (ADJP (RB exogenously) (VBN added))
          (NN Delta) (CD 1))
        (PRN (-LRB- -LRB-)
          (NP (NN open) (NN bars-IgG) (NN control))
          (-RRB- -RRB-))))
    (, ,)
    (NP
      (NP (NN TCR) (NN activation))
      (PRN (-LRB- -LRB-)
        (PP (IN with)
          (NP (JJ anti-CD3/anti-CD28) (NNS antibodies)))
        (-RRB- -RRB-)))
    (VP (VBD up-regulated)
      (NP (NN Hes-1) (NNS levels))
      (PP (IN in)
        (NP (DT a) (JJ LY294002-sensitive) (NN manner))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Significantly))
      (, ,)
      (NP (DT this) (NN induction))
      (VP (VBD was)
        (ADVP (RB also))
        (VP (VBN blocked)
          (PP (IN by)
            (NP (DT the) (NN gamma) (NN secretase) (NN inhibitor) (NN DAPT)))
          (, ,)
          (S
            (ADJP (JJ consistent)
              (PP (IN with)
                (NP
                  (NP (DT an) (JJ absolute) (NN requirement))
                  (PP (IN for)
                    (NP (NN N-IC))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB also))
      (VP (VBD studied)
        (NP
          (NP (DT the) (NN induction))
          (PP (IN of)
            (NP (NN Hes-1)))
          (PP (IN by)
            (NP
              (NP (NN Delta) (NN 1-Fc) (NN treatment))
              (PRN (-LRB- -LRB-)
                (NP (JJ closed) (NNS bars))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (PP (IN In) (DT the) (NN absence) (IN of)
        (NP (NN TCR) (NN activation)))
      (, ,)
      (NP (NN Delta) (NN 1-Fc))
      (VP (VBD induced)
        (NP
          (NP (DT a)
            (ADJP
              (ADJP (JJ small))
              (, ,)
              (CC but)
              (ADJP (JJ consistent)))
            (NN induction))
          (PP (IN of)
            (NP (NN Hes-1))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP
        (NP (NN coincidence))
        (PP (IN of)
          (NP (NN Delta) (NN 1-Fc)))
        (PP (IN with)
          (NP
            (NP (NN TCR) (NN activation))
            (PRN (-LRB- -LRB-)
              (NP (JJ anti-CD3/anti-CD28) (NNS antibodies))
              (-RRB- -RRB-)))))
      (ADVP (RB dramatically))
      (VP (VBD up-regulated)
        (NP (NN Hes-1) (NNS levels))
        (PP (IN in)
          (NP (DT a) (JJ LY294002-sensitive) (NN manner)))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Again))
      (, ,)
      (NP (DT this) (NN induction))
      (VP (VBD was)
        (ADVP (RB also))
        (VP (VBN blocked)
          (PP (IN by)
            (NP (DT the) (NN gamma) (NN secretase) (NN inhibitor) (NN DAPT))))))
    (. .)))

(
  (S
    (NP (NN LY294002))
    (ADVP (RB also))
    (VP (VBD inhibited)
      (NP
        (NP (NN Notch) (NN signalling))
        (PP (IN in)
          (NP
            (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells))
            (VP (VBN transfected)
              (PP (IN with)
                (NP
                  (NP (NN p10xCBF1-luc))
                  (CC and)
                  (NP
                    (NP (DT a) (NN Notch1) (JJ intracellular) (NN domain) (NN expression) (NN plasmid))
                    (PRN (-LRB- -LRB-)
                      (S
                        (NP (NNS data))
                        (VP (RB not) (VBN shown)))
                      (-RRB- -RRB-)))))))))
      (, ,)
      (S
        (VP (VBG demonstrating)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (NN effect))
                (PP (IN of)
                  (NP (NN PI3K)))
                (PP (IN on)
                  (NP (NN Notch))))
              (VP (VBZ is)
                (VP (VBN exerted)
                  (ADVP (RB downstream)
                    (PP (IN of)
                      (NP (NN Notch) (NN cleavage)))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP (NN TCR) (NN activation))
      (ADVP (RB dramatically))
      (VP (VBZ increases)
        (NP
          (NP (DT the) (JJ cellular) (NN response))
          (PP (TO to)
            (NP (NN Notch) (NNS signals)))
          (PP (IN in)
            (NP (JJ primary) (JJ human) (NN T) (NNS cells))))
        (PP (IN via)
          (NP
            (NP (DT a) (NN mechanism))
            (VP (VBG requiring)
              (NP (DT the) (NN PI3K-Akt) (NN pathway)))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB then))
      (VP (VBD tested)
        (SBAR (IN whether)
          (S
            (NP (NN Akt) (NN activation))
            (VP (VBZ is)
              (ADJP (JJ sufficient)
                (S
                  (VP (TO to)
                    (VP (VB boost)
                      (NP
                        (NP (NN Notch-responsiveness))
                        (PP (IN in)
                          (NP (JJ human) (NN T) (NNS cells)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Over-expression))
        (PP (IN of)
          (NP
            (NP (DT a) (JJ constitutively-active) (NN Akt) (NN construct))
            (PRN (-LRB- -LRB-)
              (NP (NN gagAkt) (CD -LSB-17))
              (-RRB- -RSB-) (-RRB- -RRB-)))))
      (VP (VBD was)
        (ADJP (JJ sufficient)
          (S
            (VP (TO to)
              (VP (VB potentiate)
                (NP
                  (NP (DT the) (NN ability))
                  (PP (IN of)
                    (NP (NN pN1-IC)))
                  (S
                    (VP (TO to)
                      (VP (VB drive)
                        (NP
                          (NP (JJ CBF1-dependent) (NN reporter) (NN activity))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP Fig.) (NN 2B))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Previous) (NNS data))
      (VP (VBZ has)
        (VP (VBN suggested)
          (SBAR (IN that)
            (S
              (NP
                (NP (NN inactivation))
                (PP (IN of)
                  (NP (NN GSK3β)))
                (PP (IN by)
                  (NP (DT the) (NN Wingless) (NN pathway))))
              (VP (VBD enhanced)
                (NP (NN Notch) (NNS signals))
                (PP (IN by)
                  (S
                    (VP (VBG preventing)
                      (NP
                        (NP (JJ inhibitory) (NN phosphorylation))
                        (PP (IN of)
                          (NP (NN N-IC)))
                        (PP (IN by)
                          (NP (NNP GSK3β) (CD -LSB-18) (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (ADVP (RB Therefore))
    (, ,)
    (PP (VBN given)
      (SBAR (IN that)
        (S
          (NP (NN Akt))
          (VP
            (VP (VBZ phoshorylates))
            (CC and)
            (VP (VBZ inactivates)
              (NP (NN GSK3β) (CD -LSB-19) (-RRB- -RSB-)))))))
    (, ,)
    (NP (PRP we))
    (VP (VBN hypothesised)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ Akt-dependent) (NN inactivation))
            (PP (IN of)
              (NP (NN GSK3β))))
          (VP (MD might)
            (VP (VB be)
              (ADJP (JJ responsible)
                (PP (IN for)
                  (NP (NN Notch) (NN potentiation)))))))))
    (. .)))

(
  (S
    (S
      (VP (TO To)
        (VP (VB address)
          (NP (DT this) (NN question)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD looked)
      (PP (IN at)
        (NP
          (NP (DT the) (JJ N1-IC-induced) (NN Notch) (NN response))
          (PP (IN in)
            (NP
              (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells))
              (VP (VBN treated)
                (PP (IN with)
                  (NP (DT the) (NN GSK3β) (NN inhibitor) (NN lithium) (NN chloride)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (VBG Increasing) (NNS concentrations))
        (PP (IN of)
          (NP (NN LiCl))))
      (VP (VBD induced)
        (NP
          (NP (DT a) (JJ dramatic) (NN increase))
          (PP (IN in)
            (NP
              (NP (NN Notch) (NN signalling))
              (PRN (-LRB- -LRB-)
                (NP (NNP Fig.) (NN 3A))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (NN contrast))
          (PP (TO to)
            (NP (JJ N1-IC) (NN overexpression)))))
      (, ,)
      (NP
        (NP (VBG triggering) (NN Notch) (NN signalling))
        (VP (VBG using)
          (NP (JJ recombinant) (NN ligand))
          (S
            (VP (TO to)
              (VP (VB ligate)
                (NP (JJ endogenous) (JJ full) (NN length) (NN Notch)))))))
      (VP (VBZ generates)
        (NP
          (ADJP (RB far) (JJR weaker))
          (NN signalling))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT This) (NN fact))
        (, ,)
        (VP (VBN coupled)
          (PP (IN with)
            (NP
              (NP (JJ limited) (NN transfection) (NN efficiency))
              (PP (IN of)
                (NP (JJ primary) (NN T) (NNS cells))))))
        (, ,))
      (VP (VBZ makes)
        (S
          (NP (PRP it))
          (ADVP (RB technically))
          (ADJP (JJ difficult)
            (S
              (VP (TO to)
                (VP (VB achieve)
                  (NP
                    (NP (JJ robust) (NN induction))
                    (PP (IN of)
                      (NP (DT a) (VBN transfected) (NN CBF1) (NN reporter) (NN construct)))
                    (PP (IN by)
                      (NP (NN Delta1-Fc)))))))))))
    (. .)))

(
  (S
    (ADVP (RB However))
    (, ,)
    (PP (IN given)
      (NP
        (NP
          (NP (DT the) (JJ large) (NN potentiation))
          (PP (IN of)
            (NP (NN Notch-responsiveness)))
          (PP (IN by)
            (NP (NN LiCl))))
        (PRN (-LRB- -LRB-)
          (NP (NNP Fig.) (NN 3A))
          (-RRB- -RRB-))))
    (, ,)
    (NP (PRP we))
    (VP (VBN hypothesised)
      (SBAR (IN that)
        (S (, ,)
          (PP (IN in) (DT the) (NN presence) (IN of)
            (NP (NN LiCl)))
          (, ,)
          (NP
            (NP (JJ robust)
              (ADJP (NN Delta1-Fc) (JJ dependent))
              (NN induction))
            (PP (IN of)
              (NP (DT a) (NN CBF1) (NN reporter))))
          (VP (MD could)
            (VP (VB be)
              (VP (VBN observed)))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD found)
        (SBAR (IN that) (, ,)
          (S
            (S
              (ADJP (JJ consistent)
                (PP (IN with)
                  (NP
                    (NP (DT the) (JJ technical) (NNS issues))
                    (VP (VBP outline)
                      (ADJP (JJ above)))))))
            (, ,)
            (NP (JJ plate-bound) (NN Delta1-Fc))
            (VP (VBZ activates)
              (NP (DT the) (NN CBF1) (NN reporter))
              (ADVP
                (ADVP (RB weakly))
                (CC and)
                (ADVP (RB unreliably)))
              (PP (IN in) (DT the) (NN absence) (IN of)
                (NP
                  (NP (NN LiCl))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Fig.) (NN 3B))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (NN LiCl))
      (ADVP (RB greatly))
      (VP (VBZ potentiates)
        (NP
          (NP (NN activation))
          (PP (IN of)
            (NP (DT the) (NN reporter)))
          (PP (IN by)
            (NP
              (NP (JJ plate-bound) (NN Delta1-Fc))
              (PRN (-LRB- -LRB-)
                (NP (NNP Fig.) (NN 3B))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP (DT the) (NN GSK3β) (NN inhibitor) (NN LiCl))
      (VP (VBZ is)
        (ADJP (JJ sufficient)
          (S
            (VP (TO to)
              (VP (VB potentiate)
                (NP
                  (NP (JJ primary) (NN Notch-responsiveness))
                  (PP (IN in)
                    (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells)))
                  (, ,)
                  (VP (VBN triggered)
                    (PP (CC either)
                      (PP (IN by)
                        (NP (JJ N1-IC) (NN expression)))
                      (, ,)
                      (CC or)
                      (PP (IN by)
                        (NP
                          (NP (NN ligation))
                          (PP (IN of)
                            (NP (JJ endogenous) (JJ full) (NN length) (NN Notch))))))
                    (PP (IN by)
                      (NP (JJ plate-bound) (NN ligand)))))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP
        (NP (NN Jurkat) (NNS T-cells))
        (, ,)
        (ADJP (JJ deficient)
          (PP (IN in)
            (NP (NN Pten) (NN expression))))))
    (, ,)
    (NP (JJ basal) (NN Akt) (NN activity))
    (VP (VBZ is)
      (NP (JJ high) (NN -LSB-15) (-RRB- -RSB-))
      (, ,)
      (SBAR (IN so)
        (S
          (NP (PRP we))
          (VP (VBN expected)
            (NP (NN GSK3β))
            (S
              (VP (TO to)
                (VP (VB be)
                  (ADVP (RB maximally))
                  (VP (VBN inhibited)))))))))
    (. .)))

(
  (S
    (S
      (S
        (ADJP (JJ Consistent)
          (PP (IN with)
            (NP (DT this)))))
      (, ,)
      (NP (NN LiCl) (NN treatment))
      (VP (VBD did) (RB not)
        (VP (VB exert)
          (NP (DT any) (JJ further) (NN effect))
          (PP (IN on)
            (NP
              (NP (JJ Delta1-induced) (NN signalling))
              (PP (IN in)
                (NP
                  (NP (JJ Jurkat-N2) (NNS cells))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Fig.) (NN 3C))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB investigate)
            (SBAR (IN whether)
              (S
                (NP
                  (NP (JJ PI3K-dependent) (NN regulation))
                  (PP (IN of)
                    (NP (NN Notch) (NN responsiveness))))
                (VP (MD may)
                  (VP (VB be)
                    (NP
                      (NP (DT a) (JJ general) (NN phenomenon))
                      (VP (VBG extending)
                        (PP (IN beyond)
                          (NP (NN T-cell) (NN biology))))))))))))
      (, ,)
      (NP (PRP we))
      (VP (VBD took)
        (NP
          (NP (NN advantage))
          (PP (IN of)
            (NP
              (NP (DT a) (JJ Notch-dependent) (NN CHO) (NN cell) (NN reporter) (NN assay))
              (SBAR
                (WHNP (WDT which))
                (S
                  (NP (PRP we))
                  (VP (VBP have)
                    (ADVP (RB previously))
                    (VP (VBN described)
                      (NP (NN -LSB-20))))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT this) (NN assay)))
      (, ,)
      (NP
        (NP (NN CHO) (NNS cells))
        (SBAR
          (WHNP (WDT which))
          (S
            (ADVP (RB stably))
            (VP (VBP express)
              (NP
                (NP (DT a) (JJ human) (NN Notch2) (NN receptor) (NN cDNA))
                (CC and)
                (NP
                  (NP (DT a) (JJ CBF1-dependent) (NN luciferase) (NN reporter) (NN construct))
                  (PRN (-LRB- -LRB-)
                    (NP (VBN termed) (NN CHO-N2))
                    (-RRB- -RRB-))))))))
      (VP (VBP are)
        (VP (VBN co-cultured)
          (PP (IN with)
            (NP
              (NP (DT a) (JJ second) (NN CHO) (NN cell) (NN line))
              (SBAR
                (WHNP (WDT which))
                (S
                  (ADVP (RB stably))
                  (VP (VBZ expresses)
                    (NP
                      (NP (DT the) (JJ full-length) (JJ human) (NN Delta1) (NN cDNA))
                      (PRN (-LRB- -LRB-)
                        (NP (VBN termed) (NN CHO-hDelta1))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (NP (NN CHO-hDelta1) (NNS cells))
    (VP (VBP trigger)
      (NP
        (NP (DT a) (JJ dose-dependent) (NN luciferase) (NN response))
        (PP (TO to)
          (NP (DT the) (JJ CHO-N2) (NNS cells))))
      (, ,)
      (SBAR (IN whilst)
        (S
          (NP (NN control) (NN CHO) (JJ parental) (NNS cells))
          (VP (VBP fail)
            (S
              (VP (TO to)
                (VP (VB activate)
                  (NP
                    (NP (DT the) (NN Notch) (NN pathway))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Fig.) (NN 4A))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB next))
      (VP (VBD asked)
        (SBAR (IN if)
          (S
            (NP
              (NP (NN activation))
              (PP (IN of)
                (NP (DT the) (NN PI3K) (NN pathway))))
            (VP (VBD influenced)
              (NP (NN Notch) (NNS signals))
              (PP (IN in)
                (NP (DT this) (NN assay) (NN system))))))))
    (. .)))

(
  (S
    (S
      (S
        (SBAR (IN As)
          (S
            (VP (VBN predicted)
              (PP (IN from)
                (NP
                  (NP (PRP$ our) (NN T-cell) (NNS studies))
                  (, ,)
                  (PP (VBG including)
                    (NP
                      (NP (NN insulin))
                      (PP (IN in)
                        (NP (DT the) (NN culture) (NN medium))))))))))
        (VP (VBD potentiated)
          (NP (NN Notch) (NN signalling))))
      (, ,)
      (CC and)
      (S
        (NP (DT this) (NN effect))
        (VP (VBD was)
          (VP (VBN blocked)
            (ADVP (RB almost) (RB completely))
            (PP (IN by)
              (NP
                (NP (NN inclusion))
                (PP (IN of)
                  (NP (NN LY294002)))))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 4B))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (PP (IN From)
        (NP
          (NP (PRP$ our) (NNS observations))
          (PP (IN with)
            (NP (NNS T-cells)))))
      (, ,)
      (NP (PRP we))
      (VP (VBP hypothesisesd)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN GSK3β) (NN inhibition))
              (PP (IN with)
                (NP (NN LiCl))))
            (VP (MD could)
              (VP (VB substitute)
                (PP (IN for)
                  (NP (NN insulin)))
                (PP (IN in)
                  (S
                    (VP (VBG potentiating)
                      (NP
                        (NP (NN Notch) (NN signalling))
                        (VP (VBN induced)
                          (PP (IN by)
                            (NP (NN CHO-hDelta1) (NNS cells))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN LiCl))
      (VP (VBZ does) (RB indeed)
        (VP (VB potentiate)
          (NP (NN Notch) (NN signalling))
          (PP (IN in)
            (NP (DT the) (NN CHO) (NN co-culture) (NN system)))
          (, ,)
          (S
            (VP (VBG leading)
              (PP (TO to)
                (NP
                  (NP (DT a) (JJ substantial) (NN enhancement))
                  (PP (IN of)
                    (NP
                      (NP (JJ ligand-dependent) (NN reporter) (NN activity))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Fig.) (NN 4C))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (ADVP (RB then))
    (VP (VBD extended)
      (NP (PRP$ our) (NN study))
      (ADVP (RB further))
      (, ,)
      (NP (DT this) (NN time))
      (PP (IN into)
        (NP
          (NP (JJ primary) (NNS neurons))
          (, ,)
          (NP (NN cell) (NNS types))))
      (SBAR
        (WHADVP (WRB where))
        (S
          (NP (NN Notch))
          (VP (VBZ plays)
            (NP (DT an) (VBG emerging) (NN role))
            (PP (IN in)
              (NP
                (NP (NNS processes))
                (PP (JJ such) (IN as)
                  (NP
                    (NP (JJ dendritic) (NN patterning))
                    (CC and)
                    (NP (JJ synaptic) (NN plasticity) (CD -LSB-21,22)))))))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (SBAR (IN As)
        (S
          (VP (VBN observed)
            (PP (IN with)
              (NP (NNS T-cells))))))
      (, ,)
      (NP
        (NP (NN inhibition))
        (PP (IN of)
          (NP (NN GSK3β)))
        (PP (IN with)
          (NP (NN lithium) (NN chloride))))
      (ADVP (RB strongly))
      (VP (VBD enhanced)
        (NP
          (NP (DT the) (NN level))
          (PP (IN of)
            (NP (NN Notch) (NN signalling)))
          (PP (IN in)
            (NP (NN rat) (JJ primary) (JJ hippocampal) (NNS neurons))))
        (PP (IN in)
          (NP (DT a) (JJ dose-dependent) (NN manner)))
        (-LRB- -LRB-)
        (NP (NNP Fig.) (CD 4D))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ PI3K-activating) (NNS neurotrophins))
        (PP (JJ such) (IN as)
          (NP (NN BDNF))))
      (VP (VBP regulate)
        (NP
          (NP
            (NP (NN cell) (NN survival))
            (, ,)
            (NP (NN proliferation))
            (CC and)
            (NP (NN differentiation)))
          (PP (IN of)
            (NP (CC both)
              (NP
                (ADJP (JJ peripheral)))
              (CC and)
              (NP (JJ central) (NNS neurons))
              (NP (NN -LSB-23))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (ADVP (RB Strikingly))
      (, ,)
      (S
        (NP (NN BDNF) (NN treatment))
        (VP (VBD potentiated)
          (NP (JJ pN1-IC-driven) (NN reporter) (NN activity))))
      (, ,)
      (CC and)
      (S
        (NP (DT this))
        (VP (VBD was)
          (VP (VBN abrogated)
            (PP (IN by)
              (NP
                (NP (NN treatment))
                (PP (IN with)
                  (NP (NN LY294002)))))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 4D))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Pten) (NN transfection))
      (VP (VBD ablated)
        (NP
          (ADJP (CC both)
            (ADJP (JJ basal))
            (CC and)
            (ADJP (JJ BDNF-stimulated)))
          (NN reporter) (NN signalling))
        (, ,)
        (S
          (ADVP (RB further))
          (VP (VBG underlining)
            (NP
              (NP (DT the) (NN role))
              (PP (IN of)
                (NP (DT the) (NN PI3K) (NN pathway)))
              (PP (IN in)
                (S
                  (VP (VBG promoting)
                    (NP
                      (NP (NN Notch-responsiveness))
                      (PP (IN in)
                        (NP (NNS neurons))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Moreover))
      (, ,)
      (NP
        (NP (NN over-expression))
        (PP (IN of)
          (NP
            (ADJP (RB constitutively) (JJ active))
            (NN gagAkt))))
      (VP (VBD was)
        (ADJP (JJ sufficient)
          (S
            (VP (TO to)
              (VP (VB potentiate)
                (NP (JJ pN1-IC-driven) (NN reporter) (NN activity))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Fig.) (CD 4E))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (S
        (S
          (VP (TO To)
            (ADVP (RB further))
            (VP (VB reinforce)
              (NP (DT this) (NN finding)))))
        (, ,)
        (S
          (NP
            (NP (NN expression))
            (PP (IN of)
              (NP
                (NP (DT a) (JJ constitutively-active) (NN GSK3β) (NN construct))
                (PRN (-LRB- -LRB-)
                  (NP (NN S9A))
                  (-RRB- -RRB-))))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBZ is)
                  (ADJP (JJ resistant)
                    (PP (TO to)
                      (NP
                        (NP (NN inactivation))
                        (PP (IN by)
                          (NP (NN Akt)))))))))
            (, ,))
          (VP (VBD prevented)
            (NP
              (NP (NN BDNF) (NN induction))
              (PP (IN of)
                (NP (NN Notch) (NN responsiveness)))))))
      (PRN (-LRB- -LRB-)
        (NP (NNP Fig.) (CD 4E))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP
        (NP (NN expression))
        (PP (IN of)
          (NP (JJ wild-type) (NNS GSK3β)))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBZ is)
              (VP (VBN inhibited)
                (PP (IN by)
                  (NP (NN Akt) (NN activity)))))))
        (, ,))
      (VP (VBD failed)
        (S
          (VP (TO to)
            (ADVP (RB significantly))
            (VP (VB reduce)
              (NP (NN reporter) (NN activity)))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN As)
        (S
          (VP (VBN observed)
            (PP (IN with)
              (NP (NNS T-cells))))))
      (, ,)
      (NP
        (NP (NN inhibition))
        (PP (IN of)
          (NP (NN GSK3β)))
        (PP (IN with)
          (NP (NN lithium) (NN chloride))))
      (ADVP (RB strongly))
      (VP (VBD enhanced)
        (NP
          (NP (DT the) (NN level))
          (PP (IN of)
            (NP (NN Notch) (NN signalling))))
        (PP (IN in)
          (NP (DT a) (JJ dose-dependent) (NN manner)))
        (-LRB- -LRB-)
        (NP (NNP Fig.) (CD 4D))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (NP (DT the) (NN PI3K-Akt) (NN pathway))
      (ADVP (RB positively))
      (VP (VBZ regulates)
        (NP (NN Notch) (NNS signals))
        (PP (IN via)
          (NP
            (NP (NN GSK3β))
            (PP (IN in)
              (NP
                (NP (NNS neurons))
                (CONJP (RB as) (RB well) (IN as))
                (NP (NNS T-cells))))))
        (, ,)
        (SBAR (IN as)
          (S
            (VP (VBN summarised)
              (PP (IN in)
                (NP (NNP Fig.) (CD 5))))))))
    (. .)))

(
  (S
    (NP (NN Discussion))))

(
  (S
    (S
      (NP
        (NP (DT The)
          (ADJP
            (ADJP (JJ dynamic))
            (CC and)
            (ADJP (JJ interactive)))
          (NN nature))
        (PP (IN of)
          (NP (JJ intracellular) (NN communication))))
      (VP (VBZ dictates)
        (SBAR (IN that)
          (S
            (NP (NNS cells))
            (VP (VBP are)
              (PP (IN in)
                (NP
                  (NP (NN receipt))
                  (PP (IN of)
                    (NP (JJ multiple) (JJ environmental) (NNS signals)))))
              (PP (IN at)
                (NP (DT any) (JJ given) (NN time))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (JJ cellular) (NN output))
        (VP (MD must)
          (VP (VB represent)
            (NP
              (NP (DT a) (JJ net) (NN response))
              (PP (TO to)
                (NP
                  (NP (DT a) (JJ diverse) (NN set))
                  (PP (IN of)
                    (NP (NNS cues)))))))))
      (, ,)
      (CC and)
      (ADVP (RB therefore))
      (S
        (NP
          (NP (DT the) (NNS pathways))
          (VP (VBG mediating)
            (NP (DT these) (NNS responses))))
        (VP (VBP are)
          (ADVP (RB frequently))
          (VP (VBN integrated)))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS studies))
      (VP (VBP demonstrate)
        (PP (IN for)
          (NP (DT the) (JJ first) (NN time)))
        (SBAR (IN that)
          (S
            (NP (NN PI3K) (NN activity))
            (ADVP (RB strongly))
            (VP (VBZ potentiates)
              (NP
                (NP (NN Notch) (NN responsiveness))
                (PP (IN in)
                  (NP (JJ diverse) (NN cell) (NNS types)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN Given)
        (NP
          (NP (DT the) (JJ vital) (NN nature))
          (PP (IN of)
            (NP
              (NP (NN PI3K))
              (CC and)
              (NP (NN Notch))))
          (PP (IN in)
            (S
              (VP (VBG controlling)
                (NP
                  (NP (JJ cellular) (NN survival))
                  (CC and)
                  (NP (NN differentiation))))))))
      (, ,)
      (NP
        (NP (DT the) (NNS implications))
        (PP (IN of)
          (NP (DT this) (NN finding))))
      (VP (VBP are)
        (ADJP (JJ far-reaching))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Ligation))
        (PP (IN of)
          (NP (NN lymphocyte) (NN antigen) (NNS receptors))))
      (VP (VBZ leads)
        (PP (TO to)
          (NP
            (NP (NN activation))
            (PP (IN of)
              (NP (NN PI3K)))))
        (, ,)
        (S
          (VP (VBG initiating)
            (NP
              (NP (DT a)
                (ADJP
                  (ADJP (JJ diverse))
                  (CC and)
                  (ADJP (JJ wide-ranging)))
                (NN set))
              (PP (IN of)
                (NP
                  (NP (NN signalling) (NNS pathways))
                  (PRN (NN -LSB-2) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NNS findings)
        (SBAR (IN that)
          (S
            (NP (NN PI3K) (NN activation))
            (VP (VBZ enhances)
              (NP (NN Notch) (NN signalling))))))
      (VP (VBZ leads)
        (S
          (NP (PRP us))
          (VP (TO to)
            (VP (VB suggest)
              (SBAR (IN that)
                (S
                  (NP (NN Notch) (NN pathway) (NN activation))
                  (VP (MD might)
                    (VP (VB be)
                      (NP
                        (NP (DT an) (JJ inherent) (NN consequence))
                        (PP (IN of)
                          (NP (NN lymphocyte) (NN activation)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBZ positions)
        (NP (DT the) (NN Notch) (NN pathway))
        (PP (IN as)
          (NP
            (NP (DT a) (JJ central) (NN mediator))
            (PP (IN of)
              (NP
                (NP (JJ antigen-dependent) (NN stimulation))
                (PP (IN of)
                  (NP (JJ immune) (NNS cells)))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS T-cells))
      (VP
        (VP (VBP are)
          (ADJP (RB entirely) (JJ quiescent)
            (PP (IN in)
              (NP
                (NP (DT the) (NN absence))
                (PP (IN of)
                  (NP (NN antigen) (NNS signals)))))))
        (, ,)
        (CC but)
        (VP (VBP are)
          (VP (VBN shifted)
            (ADVP (RB rapidly))
            (PP (IN into)
              (NP
                (NP (DT a) (NN state))
                (PP (IN of)
                  (NP
                    (NP (NN activation))
                    (PP (VBG following)
                      (NP (NN TCR) (NN ligation)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (JJ Inappropriate) (NN control))
          (PP (IN of)
            (NP (DT this) (NN activation))))
        (VP (MD can)
          (VP (VB lead)
            (PP (TO to)
              (NP (JJ autoimmune) (NN disease))))))
      (, ,)
      (CC and)
      (S
        (NP (RB therefore) (JJ negative) (NN feedback) (NNS loops))
        (VP (VBP are)
          (NP
            (NP (DT an) (JJ inherent) (NN feature))
            (PP (IN of)
              (NP (NN T-cell) (NN biology)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Recent) (NNS data))
      (VP (VBP show)
        (SBAR (IN that)
          (S
            (NP (NN Notch) (NNS signals))
            (VP (VBP block)
              (NP (NN Akt) (NN activation))
              (PP (IN in)
                (NP (JJ peripheral) (JJ CD4+) (NNS T-cells)
                  (NP (CD -LSB-13)))))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (ADVP (RB Indeed))
    (NP (PRP we))
    (ADVP (RB also))
    (VP (VBP observe)
      (SBAR (IN that)
        (S
          (PP (IN in)
            (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells)))
          (NP
            (NP (JJ recombinant) (NN Delta1-IgG4) (NN fusion) (NN protein))
            (, ,)
            (CC or)
            (NP (JJ Notch-IC) (NN expression))
            (, ,))
          (VP (VBZ blocks)
            (NP
              (NP (JJ TCR-mediated) (NN phosphorylation))
              (PP (IN of)
                (NP
                  (NP
                    (NP (NN Akt))
                    (CC and)
                    (NP (NN GSK3β)))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN GM))
                      (, ,)
                      (NP (NN BC))
                      (, ,)
                      (NP (JJ unpublished) (NNS data)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (S
        (SBAR (IN Although)
          (S
            (NP (NN Akt) (NN activation))
            (VP (VBZ is)
              (ADJP (JJ essential)
                (PP (IN for)
                  (NP
                    (NP (NN production))
                    (PP (IN of)
                      (NP
                        (NP (NNS cytokines))
                        (PP (JJ such) (IN as)
                          (NP
                            (NP (NN IL2))
                            (CC and)
                            (NP (NN IFNγ))))))
                    (PP (IN by)
                      (NP (NNS T-cells) (CD -LSB-24) (-RRB- -RSB-)))))))))
        (, ,)
        (NP (JJ constitutive) (NN activity))
        (VP (VBZ is)
          (VP (VBN associated)
            (PP (IN with)
              (NP (JJ cellular) (NN transformation) (CD -LSB-25)))))
        (-RRB- -RSB-))
      (, ,)
      (CC and)
      (S
        (ADVP (RB therefore))
        (NP
          (NP (DT the) (NN existence))
          (PP (IN of)
            (NP
              (NP (DT a) (JJ negative) (NN feedback) (NN loop))
              (S
                (VP (TO to)
                  (VP (VB limit)
                    (NP (JJ antigen-dependent) (NN Akt) (NN activation))))))))
        (VP (MD would)
          (VP (VB appear)
            (ADJP (JJ rational))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (S
                (NP (JJ co-incident) (NN Notch) (NNS signals))
                (VP (VBP are)
                  (VP (VBN enhanced)
                    (PP (IN upon)
                      (NP (NN TCR) (NN activation))))))
              (, ,)
              (CC and)
              (S
                (NP (PRP we))
                (VP (VBP hypothesise)
                  (SBAR (IN that)
                    (S
                      (PP (IN by)
                        (S
                          (VP (VBG inhibiting)
                            (NP (NN Akt) (NN activity)))))
                      (, ,)
                      (NP (VBN enhanced) (NN Notch) (NN signalling))
                      (VP (MD may)
                        (VP (VB constitute)
                          (NP
                            (NP (DT a) (JJ negative) (NN feedback) (NN control))
                            (VP (VBG impacting)
                              (PP (IN upon)
                                (NP (JJ peripheral) (NN T-cell) (NN activation))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADJP (JJ interesting)
          (S
            (VP (TO to)
              (VP (VB note)
                (SBAR (IN that)
                  (S
                    (S
                      (PP (IN whilst)
                        (NP (DT the) (NN model)))
                      (NP (PRP we))
                      (VP (VBP propose)
                        (S
                          (VP (VBZ is)
                            (ADJP (JJ consistent)
                              (PP (IN with)
                                (NP
                                  (NP (DT the) (NNS data))
                                  (VP (VBN generated)
                                    (PP (IN in)
                                      (NP (JJ peripheral) (NNS T-cells)))))))))))
                    (, ,)
                    (S
                      (NP
                        (NP (DT a) (NN number))
                        (PP (IN of)
                          (NP (NNS studies))))
                      (VP (VBP suggest)
                        (SBAR (IN that)
                          (S
                            (NP (DT the) (JJ opposite))
                            (VP (VBZ is)
                              (ADJP (JJ true)
                                (NP (CD -LSB-26-28) (-RRB- -RSB-))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNP Ciofani) (FW et) (FW al))
      (VP (VBP demonstrate)
        (SBAR (IN that)
          (S
            (PP (IN during)
              (NP
                (NP (DT the) (JJS earliest) (NNS stages))
                (PP (IN of)
                  (NP (NN T-cell) (NN development)))
                (PP (IN in)
                  (NP (DT the) (NN thymus)))))
            (NP (NN Notch) (NNS signals))
            (VP (VBP co-operate)
              (PP (IN with)
                (NP (NN pre-TCR) (NN signalling)))
              (S
                (VP (TO to)
                  (VP (VB activate)
                    (NP (JJ Akt-dependent) (NN metabolism))
                    (, ,)
                    (S
                      (ADVP (RB thereby))
                      (VP (VBG promoting)
                        (NP
                          (NP (NN expansion))
                          (PP (IN of)
                            (NP
                              (NP (DT those) (NNS T-cells))
                              (SBAR
                                (WHNP (WDT which))
                                (S
                                  (VP (VBP have)
                                    (VP (VBN undergone)
                                      (NP (JJ favourable) (NN TCR) (NN rearrangement)))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ functional) (NN outcome))
        (PP (IN of)
          (NP (JJ PI3K/Notch) (NN pathway) (NN interaction))))
      (ADVP (RB thus))
      (VP (VBZ appears)
        (S
          (VP (TO to)
            (VP (VB reverse)
              (PP (IN from)
                (S
                  (VP (VBG developing)
                    (PP (TO to)
                      (NP
                        (NP (JJ mature) (NNS T-cells))
                        (, ,)
                        (NP
                          (NP (DT an) (NN observation))
                          (SBAR
                            (WHNP (WDT which))
                            (S
                              (ADVP (RB further))
                              (VP (VBZ underlines)
                                (NP
                                  (NP (DT the) (NN ability))
                                  (PP (IN of)
                                    (NP (DT the) (NN Notch) (NN pathway)))
                                  (S
                                    (VP (TO to)
                                      (VP (VB perform)
                                        (NP
                                          (ADJP
                                            (ADJP (JJ multiple))
                                            (, ,)
                                            (ADJP (JJ context-dependent))
                                            (, ,))
                                          (NNS tasks))
                                        (PP (IN during)
                                          (NP (NN development)))))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT a) (JJ molecular) (NN understanding))
              (PP (IN of)
                (SBAR
                  (WHADVP (WRB how))
                  (S
                    (NP (NN Notch))
                    (VP (MD can)
                      (VP (VB function)
                        (PP (IN as)
                          (NP
                            (NP (DT a) (JJ bi-directional) (NN regulator))
                            (PP (IN of)
                              (NP (NN Akt) (NN activity)))))))))))
            (VP (VBZ is)
              (NP (DT a) (NN research) (NN priority)))))))
    (. .)))

(
  (S
    (S
      (NP (PRP$ Our) (NN data))
      (ADVP (RB strongly))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (NP (NN PI3K) (NN activity))
            (VP (VBZ links)
              (PP (TO to)
                (NP (DT the) (NN Notch) (NN signalling) (NN pathway)))
              (PP (IN through)
                (NP
                  (NP (JJ Akt-mediated) (NN inactivation))
                  (PP (IN of)
                    (NP
                      (NP (NN GSK3β))
                      (, ,)
                      (NP
                        (NP (DT a) (JJ known) (JJ downstream) (NN effector))
                        (PP (IN of)
                          (NP (NN Akt)))))))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP
        (NP (NN support))
        (PP (IN of)
          (NP (DT this) (NN data)))))
    (, ,)
    (NP
      (NP (NN PI3K))
      (CC and)
      (NP (NN GSK3β) (CD -LSB-18,28,29) (-RRB- -RSB-)))
    (VP (VBP have) (DT both)
      (VP (VBN been)
        (VP (VBN identified)
          (PP (IN as)
            (NP
              (NP (NN binding) (NNS partners))
              (PP (IN for)
                (NP
                  (NP (NN N-IC))
                  (PP (IN in)
                    (NP (NN immunoprecipitation) (NNS studies))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN GSK3β))
      (VP (VBZ has)
        (ADVP (RB also))
        (ADVP (RB previously))
        (VP (VBN been)
          (VP (VBN positioned)
            (PP (IN as)
              (NP
                (NP (DT a) (NN component))
                (PP (IN of)
                  (NP (DT the) (JJ downstream) (NN Notch) (NN signalling) (NN pathway)))))
            (PP (IN in)
              (NP
                (NP (JJ lateral) (NN inhibition))
                (PP (IN in)
                  (NP (FW Drosophila) (NN -LSB-30) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NN GSK3β) (NN activity))
    (VP
      (VP (VBZ is)
        (VP (VBN inhibited)
          (ADVP (RB downstream)
            (PP (IN of)
              (NP (CC both)
                (DT the)
                (NP
                  (NP (NN wingless))
                  (CC and)
                  (NP (NN PI3K)))
                (NNS pathways))))))
      (, ,)
      (CC and)
      (ADVP (RB thus))
      (VP (VBZ represents)
        (NP
          (NP (DT a) (JJ convergent) (NN site))
          (PP (IN for)
            (NP
              (NP (NN integration))
              (PP (IN of)
                (NP (JJ extracellular) (NNS signals)))
              (PP (IN with)
                (NP (DT the) (NN Notch) (NN pathway))))))))
    (. .)))

(
  (S
    (ADVP (RB Indeed))
    (, ,)
    (S
      (VP (VBG inhibiting)
        (NP (NN GSK3β) (NN activity))
        (PP (IN by)
          (S
            (VP (VBG activating)
              (NP
                (NP (DT the) (NN wingless) (NN pathway))
                (PP (IN with)
                  (NP (NN Wnt-1)))))))))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB enhance)
                (NP (NN Notch-dependent) (NN reporter) (NN activity))
                (PP (IN in)
                  (NP (NN NIH-3T3) (NNS cells) (CD -LSB-18) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VB note) (, ,)
        (ADVP (RB however))
        (, ,)
        (SBAR (IN that)
          (S
            (SBAR (IN although)
              (S
                (NP
                  (NP (DT an) (NN interaction))
                  (PP (IN between)
                    (NP
                      (NP (NN GSK3β))
                      (CC and)
                      (NP (NN Notch)))))
                (VP (VBZ seems)
                  (ADVP (RB conclusively))
                  (VP (VBN proven)))))
            (, ,)
            (NP
              (NP (DT the) (JJ functional) (NNS consequences))
              (PP (IN of)
                (NP (DT this) (NN interaction))))
            (VP (VBP are) (RB not)
              (ADJP (JJ consistent)
                (PP (IN between)
                  (NP (JJ different) (NNS studies)))))))))
    (. .)))

(
  (S
    (SBAR (IN Whilst)
      (S
        (NP (PRP$ our) (NN data))
        (VP (VBZ agrees)
          (PP (IN with)
            (NP
              (NP (DT that))
              (PP (IN of)
                (NP
                  (NP (NNP Espinosa) (FW et) (FW al.))
                  (CD -LSB-18) (-RRB- -RSB-)))
              (, ,)
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBZ is)
                    (SBAR (IN that)
                      (S
                        (NP (NN GSK3β) (NN activity))
                        (VP (VBZ inhibits)
                          (NP (NN Notch) (NN signalling)))))))))))))
    (, ,)
    (NP
      (NP (NNS data))
      (PP (IN from)
        (NP
          (NP (DT the) (NNP Nye) (NN laboratory))
          (PP (IN in)
            (NP (JJ GSK3β-deficient) (JJ murine) (JJ embryonic) (NNS fibroblasts))))))
    (VP (VBZ demonstrates)
      (SBAR (IN that)
        (S
          (NP (NN GSK3β))
          (VP
            (VP (VBZ phosphorylates))
            (CC and)
            (VP (VBZ stabilises)
              (ADJP (JJ Notch-IC)))
            (, ,)
            (S
              (VP (VBG leading)
                (PP (TO to)
                  (NP (VBN enhanced) (NN signalling) (NN -LSB-29))))))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Although)
        (S
          (NP (PRP we))
          (VP (VBP have)
            (NP
              (NP (DT no) (JJ definitive) (NN explanation))
              (PP (IN for)
                (NP (DT these) (JJ experimental) (NNS differences)))))))
      (, ,)
      (NP (PRP it))
      (VP (VBZ is)
        (ADJP (JJ possible))
        (SBAR (IN that)
          (S (, ,)
            (SBAR (IN as)
              (S
                (VP (VBN discussed)
                  (ADVP (RB above))
                  (PP (IN for)
                    (NP
                      (NP (NNS thymocytes))
                      (CC and)
                      (NP (NNS T-cells)))))))
            (, ,)
            (NP
              (NP (DT the) (NN effect))
              (PP (IN of)
                (NP (NN GSK3b)))
              (PP (IN on)
                (NP (NN Notch))))
            (VP (VBZ changes)
              (PP (IN between)
                (NP
                  (ADJP
                    (ADJP (JJ embryonic))
                    (CC and)
                    (ADJP (JJ mature)))
                  (NNS tissues))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NN Notch) (POS 's))
          (NN role))
        (PP (IN during)
          (NP (JJ embryonic) (NN development))))
      (VP (VBZ is) (RB not)
        (VP
          (VP (TO to)
            (ADVP (RB directly))
            (NP
              (NP (NN program))
              (JJ neuronal) (NN differentiation)
              (NP (PRP itself))))
          (, ,)
          (CC but)
          (VP (TO to)
            (VP (VB inhibit)
              (NP (DT this) (NN cell) (NN fate) (NN choice))
              (PP (IN in)
                (NP (JJ neighbouring) (NNS cells)))
              (PP (IN during)
                (NP (DT the) (JJ lateral) (NN inhibition) (NN process) (CD -LSB-8) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (PP (IN During)
        (NP (NN neurogenesis)))
      (, ,)
      (NP (DT this))
      (VP (VBZ is)
        (VP (VBN achieved)
          (PP (IN by)
            (NP
              (NP (NN Notch) (NN target) (NNS genes))
              (VP (VBG blocking)
                (NP
                  (NP (NN transcription))
                  (PP (IN of)
                    (NP
                      (NP (JJ pro-neural) (NN transcription) (NNS factors))
                      (PP (JJ such) (IN as)
                        (NP (NN MASH-1))))))))))))
    (. .)))

(
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP
      (NP (JJ conditional) (NN deletion))
      (PP (IN of)
        (NP (NN Pten)))
      (PP (IN in)
        (NP (JJ neural) (NNS progenitors))))
    (VP (VBZ leads)
      (PP (TO to)
        (NP
          (NP (JJ dramatic) (NNS alterations))
          (PP (IN in)
            (NP (NN brain) (NN architecture)))
          (, ,)
          (SBAR
            (WHNP
              (NP (DT an) (NN observation))
              (WDT which))
            (S
              (NP (DT the) (NNS authors))
              (VP (VBP attribute)
                (PP (TO to)
                  (NP
                    (NP (VBN increased) (NN proliferation))
                    (CC and)
                    (NP
                      (ADJP (JJ self-renewal)
                        (PP (IN of)
                          (NP (JJ neural) (NN stem) (NN cell) (NNS populations))))
                      (NN -LSB-31) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (PP (VBN Given)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NNS data))
              (VP (VBN presented)
                (ADVP (RB here))))
            (VP (VBZ establishes)
              (NP
                (NP (DT the) (JJ Notch-suppressing) (NN capability))
                (PP (IN of)
                  (NP (NN Pten))))))))
      (, ,)
      (NP
        (NP (VBN deregulated) (NN renewal))
        (PP (IN of)
          (NP
            (NP (NNS progenitors))
            (PP (IN in)
              (NP (DT these) (NNS mice))))))
      (VP (MD may)
        (VP (VB be)
          (PP (IN in)
            (NP
              (NP (NN part))
              (PP (IN due) (TO to)
                (NP (VBN enhanced) (NN Notch) (NN signalling))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN hypothesis))
      (VP (VBZ awaits)
        (NP (NN testing))))
    (. .)))

(
  (S
    (S
      (NP (NN Notch))
      (ADVP (RB also))
      (VP (VBZ plays)
        (NP
          (NP (DT an) (VBG emerging) (NN role))
          (PP (IN in)
            (NP (JJ differentiating) (NNS neurons))))
        (PP (IN by)
          (S
            (VP (VBG inhibiting)
              (NP (JJ dendritic) (NN outgrowth) (NN -LSB-21) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADJP (JJ tempting))
        (S
          (VP (TO to)
            (VP (VB speculate)
              (SBAR (IN that)
                (S
                  (NP
                    (NP (NN Notch-dependent) (JJ dendritic) (NN retraction))
                    (, ,)
                    (ADJP (JJ reliant)
                      (PP (IN on)
                        (NP (JJ neuron-neuron) (NNS interactions))))
                    (, ,))
                  (VP (VBZ is)
                    (VP (VBN augmented)
                      (PP (IN by)
                        (NP
                          (NP (JJ target-derived) (JJ neurotrophic) (NNS factors))
                          (VP (VBG promoting)
                            (NP (NN PI3K) (NN signalling))))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (VBN differentiated) (NNS neurons)))
      (, ,)
      (NP (NN Notch))
      (VP (VBZ contributes)
        (PP (TO to)
          (NP
            (NP (JJ synaptic) (NN plasticity))
            (, ,)
            (NP (NN learning))
            (CC and)
            (NP (NN memory) (NN -LSB-22,32)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ long-standing) (NN involvement))
        (PP (IN of)
          (NP
            (NP (NN BDNF))
            (CC and)
            (NP (JJ other) (NNS neurotrophins))))
        (PP (IN in)
          (NP (JJ synaptic) (NN plasticity))))
      (VP (VBP raise)
        (NP (DT the) (NN possibility)
          (SBAR (IN that)
            (S
              (NP (JJ PI3K-Notch) (NN interplay))
              (VP (VBZ is)
                (PP (IN at)
                  (NP
                    (NP (NN work))
                    (PP (IN in)
                      (NP (DT this) (NN scenario)))))
                (PP (IN as)
                  (NP (NN well)))))))))
    (. .)))

(
  (S
    (NP (NN Conclusion))))

(
  (S
    (S
      (NP (PRP$ Our) (NN data))
      (VP (VBZ demonstrates)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN potentiation))
              (PP (IN of)
                (NP (NN Notch) (NN signalling)))
              (PP (IN by)
                (NP (NN PI3K))))
            (VP (VBZ is)
              (VP (VBN conserved)
                (PP (IN in)
                  (NP (JJ ontologically-distinct) (NN cell) (NNS types))))
              (, ,)
              (S
                (VP (VBG leading)
                  (S
                    (NP (PRP us))
                    (VP (TO to)
                      (VP (VB suggest)
                        (SBAR (IN that)
                          (S
                            (NP (PRP it))
                            (VP (VBZ represents)
                              (NP
                                (NP (DT a) (JJ general) (NN mechanism))
                                (PP (IN of)
                                  (NP (NN signal) (NN integration))))
                              (S
                                (VP (VBG linking)
                                  (NP (CD two) (JJ evolutionarily-conserved) (NNS pathways))
                                  (ADVP (RB together)))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This)
        (ADJP (RB apparently) (JJ simple))
        (NN observation))
      (VP (VBZ has)
        (NP
          (NP (JJ far-reaching) (NNS implications))
          (VP (VBG regarding)
            (NP
              (NP (DT the) (NNS mechanisms))
              (SBAR
                (WHPP (IN by)
                  (WHNP (WDT which)))
                (S
                  (NP (NN stem) (NN cell)
                    (NP (JJ self-renewal))
                    (CC and)
                    (NP (NN differentiation)))
                  (VP (VBZ proceeds)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (MD will)
        (VP (VB be)
          (ADJP (JJ interesting)
            (S
              (VP (TO to)
                (VP (VB assess)
                  (NP
                    (NP (DT the) (NN relevance))
                    (PP (IN of)
                      (NP (DT this) (NN finding)))
                    (PP (IN in)
                      (NP
                        (NP (JJ other) (NN signalling) (NNS contexts))
                        (, ,)
                        (PP (JJ such) (IN as)
                          (NP
                            (NP (NN tumour) (NN formation))
                            (, ,)
                            (SBAR
                              (WHADVP (WRB where))
                              (S
                                (NP
                                  (NP (NN Notch))
                                  (CC and)
                                  (NP (NN PI3K)))
                                (VP (VBP have)
                                  (NP (JJ important) (NNS roles)))))))))))))))))
    (. .)))

(
  (S
    (NP (NNS Methods))))

(
  (S
    (S
      (NP
        (NP (NN SH-6))
        (, ,)
        (NP (NN lithium) (NN chloride))
        (, ,)
        (NP (NN LY294002))
        (, ,)
        (NP (NN Wortmannin))
        (CC and)
        (NP (NN BDNF)))
      (VP (VBD were)
        (PP (IN from)
          (NP (NN Calbiochem)))))
    (. .)))

(
  (S
    (S
      (NP (JJ Human) (NN IgG4))
      (VP (VBD was)
        (PP (IN from)
          (NP (NN Sigma)))))
    (. .)))

(
  (S
    (S
      (NP (NN Dual-Glo) (NN Luciferase) (NN assay) (NN system))
      (VP (VBD was)
        (PP (IN from)
          (NP (NN Promega)))))
    (. .)))

(
  (S
    (S
      (NP (NN pN1-IC))
      (VP (VBD was)
        (VP (VBN constructed)
          (PP (IN by)
            (S
              (VP (VBG inserting)
                (NP
                  (NP (NNS nucleotides))
                  (VP (VBG coding)
                    (PP (IN for)
                      (NP
                        (NP (DT the) (JJ intracellular) (NN domain))
                        (PP (IN of)
                          (NP (JJ human) (NN Notch1)))
                        (PRN (-LRB- -LRB-)
                          (NP (NN amino) (NNS acids)
                            (NP (NN 1758) (TO to) (CD 2557)))
                          (-RRB- -RRB-))
                        (VP (VBN preceded)
                          (PP (IN by)
                            (NP (DT an) (NN initiator) (NN ATG) (NN codon))))))))
                (PP (IN into)
                  (NP
                    (NP (DT the) (NN BamHI)
                      (CC and)
                      (NN EcoRI) (NNS sites))
                    (PP (IN of)
                      (NP
                        (NP (NN pcDNA3.1))
                        (PRN (-LRB- -LRB-)
                          (NP (NN Invitrogen))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN pAdTATA-luc))
      (VP (VBD was)
        (VP (VBN constructed)
          (PP (IN by)
            (S
              (VP (VBG inserting)
                (NP
                  (NP (DT the) (JJ Adenoviral) (JJ major) (JJ late) (NN promoter) (NN TATA) (NN sequence)
                    (NP (RB immediately) (CD 5) ('' ')))
                  (PP (IN of)
                    (NP (DT the) (NN luciferase) (NN gene))))
                (PP (IN in)
                  (NP
                    (NP (NN plasmid) (NN pGL3Basic))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Promega))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN p10xCBF1-luc))
      (VP (VBD was)
        (VP (VBN constructed)
          (PP (IN by)
            (S
              (VP (VBG inserting)
                (NP
                  (NP (CD 10) (NNS copies))
                  (PP (IN of)
                    (NP
                      (NP (DT the) (NN CBF1) (NN binding) (NN site) (CD 5) ('' '))
                      (PP (IN of)
                        (NP (DT the) (NN AdTATA) (NN box)))
                      (PP (IN in)
                        (NP (NN pAdTATA-luc))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN pTK-Renilla))
      (VP (VBD was)
        (PP (IN from)
          (NP (NN Promega)))))
    (. .)))

(
  (S
    (S
      (NP (JJ Human) (NN Pten) (NN expression) (NN construct))
      (VP (VBD was)
        (VP
          (VP (VBN generated)
            (PP (IN by)
              (NP
                (NP (NN PCR) (NN amplification))
                (PP (IN of)
                  (NP (JJ full-length) (JJ human) (NN Pten) (IN from) (JJ CD4+) (NN T-cell) (NN cDNA))))))
          (, ,)
          (CC and)
          (ADVP (RB then))
          (VP (VBN cloned)
            (PP (IN into)
              (NP
                (NP (DT the) (NN HindIII)
                  (CC and)
                  (NN EcoRI) (NNS sites))
                (PP (IN of)
                  (NP (NN pcDNA3.1)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (ADJP
          (ADJP (JJ Constitutively-active))
          (PRN (-LRB- -LRB-)
            (NP (NN gagAkt))
            (-RRB- -RRB-))
          (CC and)
          (ADJP (NN kinase) (JJ dead))
          (PRN (-LRB- -LRB-)
            (ADJP (JJ Akt-KD))
            (-RRB- -RRB-)))
        (NN Akt) (NN expression) (NNS constructs))
      (VP (VBD were)
        (NP
          (NP (DT a) (NN kind) (NN gift))
          (PP (IN from)
            (NP (NNP Dr.) (NNP Julian) (CD Downward) (CD -LSB-17) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (ADJP
          (ADJP (JJ Wild-type)
            (PRN (-LRB- -LRB-)
              (NP (NN WT))
              (-RRB- -RRB-)))
          (CC and)
          (ADJP (JJ constitutively-active)
            (PRN (-LRB- -LRB-)
              (NP (NN S9A))
              (-RRB- -RRB-))))
        (NN GSK3β) (NNS constructs))
      (VP (VBD were)
        (NP
          (NP (DT a) (NN kind) (NN gift))
          (PP (IN from)
            (NP (NNP Dr.) (NNP J.) (NNP Sadoshima) (CD -LSB-33) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (DT All) (NNS plasmids))
      (VP (VBD were)
        (VP (VBN prepared)
          (S
            (VP (VBG using)
              (NP
                (NP (DT the) (JJ EndoFree) (NN maxiprep) (NN system))
                (PRN (-LRB- -LRB-)
                  (NP (NN Qiagen))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Jurkat) (NN E6.1) (NNS cells))
        (CC and)
        (NP (NN Jurkat-N2) (NNS cells)))
      (VP (VBD were)
        (VP (VBN grown)
          (PP (IN in)
            (NP
              (NP (NN RPMI1640))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP
                    (NP
                      (ADJP (CD +10) (NN %))
                      (NN v/v))
                    (NN FBS))
                  (, ,)
                  (NP
                    (ADJP (CD 2) (NN mM))
                    (NN L-glutamine)))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Primary) (JJ CD4+) (NN T) (NNS cells))
      (VP (VBD were)
        (VP (VBN isolated)
          (PP (IN from)
            (NP (JJ freshly-collected) (NN donor) (NN blood)))
          (PP (IN as)
            (NP (VBZ follows))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Peripheral) (NN blood) (JJ mononuclear) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN prepared)
            (PP (IN by)
              (NP
                (NP (NN centrifugation))
                (PP (IN over)
                  (NP (NN Ficoll-Paque))))))
          (, ,)
          (VP (VBN incubated)
            (PP (IN with)
              (NP
                (NP (JJ anti-CD4-coated) (JJ magnetic) (NNS beads))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Miltenyi) (NNP Biotec))
                  (-RRB- -RRB-)))))
          (CC and)
          (VP (VBN selected)
            (PP (IN on)
              (NP
                (NP (NN LS) (JJ positive) (NN selection) (NNS columns))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Miltenyi) (NNP Biotec))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (PP (IN After)
        (NP (NN purification)))
      (, ,)
      (NP (JJ primary) (JJ CD4+) (NNS T-cells))
      (VP (VBD were)
        (VP (VBN cultured)
          (PP (IN in)
            (NP
              (NP (NN RPMI1640))
              (-LRB- -LRB-)
              (VP (VBN supplemented)
                (PP (IN with)
                  (NP
                    (NP
                      (NP
                        (ADJP (CD 10) (NN %))
                        (NN v/v))
                      (NN FBS))
                    (, ,)
                    (NP
                      (ADJP (CD 2) (NN mM))
                      (NN L-glutamine))
                    (CC and)
                    (NP
                      (ADJP (CD 5) (NN ×))
                      (NN 10-6M) (NN β-mercaptoethanol)))))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NN CHO-N2))
          (CC and)
          (NP (NN CHO-Delta1)))
        (NNS cells))
      (VP
        (VP (VBP have)
          (VP (VBN been)
            (VP (VBN described)
              (ADVP (RB previously))
              (S
                (NP (NN -LSB-20))
                (-RRB- -RSB-)))))
        (CC and)
        (VP (VBD were)
          (ADVP (RB routinely))
          (VP (VBN cultured)
            (PP (IN in)
              (NP
                (NP (NN DMEM))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP
                      (ADJP (CD +10) (NN %))
                      (NN v/v/FBS))
                    (, ,)
                    (NP
                      (ADJP (CD 2) (NN mM))
                      (NN L-glutamine)))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Rat) (JJ primary) (JJ hippocampal) (NNS neurons))
      (VP (VBD were)
        (VP
          (VP (VBN isolated))
          (CC and)
          (VP (VBN cultured)
            (PP (IN as)
              (NP (VBN described) (NN -LSB-34) (-RRB- -RSB-)))))
        (, ,)
        (SBAR (IN except)
          (S
            (NP (NN growth) (NNS media))
            (VP (VBD was)
              (VP (VBN supplemented)
                (PP (IN with)
                  (NP
                    (NP (NN B27))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Gibco/BRL))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Jurkat) (NN E6.1) (NNS cells))
        (CC and)
        (NP (NN Jurkat-N2) (NNS cells)))
      (VP (VBD were)
        (VP (VBN transfected)
          (S
            (VP (VBG using)
              (NP
                (NP (NN Lipofectamine) (NN 2000))
                (PRN (-LRB- -LRB-)
                  (NP (NN Invitrogen))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (NP (NNS Cells))
    (VP (VBD were)
      (VP
        (VP (JJ left)
          (NP (CD 24) (NN h))
          (ADVP (RB post-transfection)))
        (, ,)
        (VP (VBN washed))
        (, ,)
        (VP (VBN counted))
        (CC and)
        (VP (VBD re-plated)
          (PP (IN in)
            (NP (NN triplicate)))
          (PP (IN at)
            (NP
              (QP (CD 2) (CD ×) (CD 105))
              (NNS cells/well)))
          (PP (IN into)
            (NP
              (NP (JJ flat-bottomed) (JJ 96-well) (NNS plates))
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBD had)
                    (VP (VBN been)
                      (PRN (-LRB- -LRB-)
                        (SBAR
                          (WHADVP (WRB where))
                          (FRAG (JJ relevant)))
                        (-RRB- -RRB-))
                      (PP
                        (NP (JJ pre-coated) (NN o/n))
                        (IN at)
                        (NP
                          (NP (NN 4°C))
                          (PP (IN with)
                            (NP (NN hDelta1-Fc))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (VP
          (VP (VBN stimulated))
          (, ,)
          (VP (VBN incubated)
            (NP
              (NP
                (NP (NN o/n))
                (CC and)
                (NP (NN luciferase) (NN activity)))
              (VP (VBN measured)
                (S
                  (VP (VBG using)
                    (NP
                      (NP (DT the) (JJ Dual-Glo) (NN system))
                      (PRN (-LRB- -LRB-)
                        (NP (NN Promega))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NN Firefly) (NN luciferase))
          (NN signal))
        (PP (IN from)
          (NP (DT the) (NN Notch-dependent) (NN p10xCBF1-luc))))
      (VP (VBD was)
        (VP (VBN normalised)
          (S
            (VP (VBG using)
              (NP
                (NP (DT the) (NN Renilla) (NN luciferase) (NN signal))
                (VP (VBN driven)
                  (PP (IN by)
                    (NP (DT the) (NN pTK-Renilla))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Primary) (JJ CD4+) (NN T) (NNS cells))
      (VP (VBD were)
        (VP (VBN transfected)
          (S
            (VP (VBG using)
              (NP
                (NP (DT the) (NN Amaxa) (`` ') (NN nucleofection) ('' ') (NN system))
                (VP (VBG according)
                  (PP (TO to)
                    (NP
                      (NP (DT the) (NN manufacturer) (POS 's))
                      (NNS instructions))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Briefly))
      (, ,)
      (NP
        (QP (CD 5) (CD ×) (CD 106))
        (VBN purified) (JJ CD4+) (NNS T-cells))
      (VP (VBD were)
        (VP
          (VP (VBN resuspended)
            (PP (IN in)
              (NP
                (NP (CD 100) (NN μl))
                (PP (IN of)
                  (NP (DT the) (JJ appropriate) (NN Amaxa) (NN solution))))))
          (CC and)
          (VP (VBN transfected)
            (PP (IN with)
              (NP
                (NP
                  (ADJP (CD 5) (NN μg))
                  (NN plasmid) (NN DNA))
                (VP (VBG using)
                  (NP (NN Protocol) (NN U-14)))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (VP
          (VP
            (ADVP (RB immediately))
            (VBN transferred)
            (PP (TO to)
              (NP
                (NP (CD 1) (NN ml))
                (PP (IN of)
                  (NP (JJ pre-warmed) (NNS media))))))
          (, ,)
          (VP (VBN counted))
          (CC and)
          (VP (VBN plated)
            (PP (IN as)
              (NP (VBN required)))))))
    (. .)))

(
  (S
    (S
      (PP (IN After)
        (NP (NN stimulation)))
      (NP (NN luciferase) (NN activity))
      (VP (VBD was)
        (VP (VBN detected)
          (S
            (VP (VBG using)
              (NP
                (NP (DT the) (JJ Dual-glo) (NN assay) (NN system))
                (PRN (-LRB- -LRB-)
                  (NP (NN Promega))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (JJ neuronal) (NNS experiments)))
      (, ,)
      (NP (NN rat) (JJ primary) (JJ hippocampal) (NNS neurons))
      (VP (VBD were)
        (VP
          (VP (VBN transfected)
            (PP (IN after)
              (NP
                (NP (CD 9) (NNS days))
                (PP (IN in)
                  (NP
                    (NP (NN culture))
                    (VP (VBG using)
                      (NP (NN Lipofectamine) (NN 2000))))))))
          (CC and)
          (VP (VBN stimulated)
            (ADVP
              (NP (CD 36-48) (NNS hours))
              (RB later))))))
    (. .)))

(
  (S
    (S
      (NP (NN Dual-Glo) (NN Luciferase) (NNS assays))
      (VP (VBD were)
        (VP (VBN performed)
          (PP (VBG following)
            (NP (NN o/n) (NN stimulation))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (NN fusion) (NN protein))
        (VP (VBG comprising)
          (NP
            (NP (DT the) (JJ extracellular) (NN domain))
            (PP (IN of)
              (NP (JJ human) (NN Delta1)))
            (VP (VBN fused)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN Fc) (NN domain))
                  (PP (IN of)
                    (NP (JJ human) (NN IgG4)))))))))
      (VP (VBD was)
        (VP (VBN prepared)
          (PP (IN by)
            (S
              (VP (VBG inserting)
                (NP
                  (NP (DT a) (NN nucleotide) (NN sequence))
                  (VP (VBG coding)
                    (PP (IN for)
                      (NP
                        (NP (DT the) (JJ extracellular) (NN domain))
                        (PP (IN of)
                          (NP
                            (NP (JJ human) (NN Delta1))
                            (PRN (-LRB- -LRB-)
                              (NP (NN amino) (NNS acids)
                                (NP (CD 1) (TO to) (CD 537)))
                              (-RRB- -RRB-))))))))
                (PP (IN into)
                  (NP
                    (NP (DT the) (NN expression) (NN vector) (CD pCON©))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Lonza) (NNP Biologics))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN plasmid))
      (VP (VBD was)
        (VP (VBN expressed)
          (PP (IN in)
            (NP
              (NP (NN CHO) (NNS cells))
              (, ,)
              (VP (VBN purified)
                (PP (IN by)
                  (NP
                    (NP (NN affinity) (NN chromatography))
                    (PP (IN on)
                      (NP
                        (NP
                          (NP (NN ProteinA-Sepharose))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP Amersham) (NNP Biosciences))
                            (-RRB- -RRB-)))
                        (PP (IN before)
                          (NP
                            (NP (NN concentration))
                            (CC and)
                            (NP (NN buffer) (NN exchange))))
                        (PP (IN into)
                          (NP (NNS PBS)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Batch) (NN activity))
        (PP (IN of)
          (NP (DT this) (NN protein))))
      (VP (VBD was)
        (VP (VBN confirmed)
          (PP (IN as)
            (NP
              (ADJP (RB previously) (VBN described))
              (NN -LSB-35)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (VP (TO To)
        (VP (VB assess)
          (NP
            (NP (DT the) (NN effect))
            (PP (IN of)
              (NP (VBN isolated) (NN Delta1-Fc) (NN signalling)))
            (PP (IN on)
              (NP
                (NP (NN Jurkat-N2))
                (CC and)
                (NP (JJ CD4+) (NNS T-cells))))))))
    (, ,)
    (NP
      (ADJP
        (ADJP (JJ 96-))
        (CC or)
        (ADJP (JJ 24-well)))
      (NNS plates))
    (VP (VBD were)
      (VP (VBN coated)
        (ADVP (JJ overnight))
        (PP (IN at)
          (NP (NN 4°C)))
        (PP (IN with)
          (NP
            (NP (NN anti-hIgG4))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (CD 1) (NN μg/ml))
                (, ,)
                (NP (NNP BD) (NNP Biosciences)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Plates))
      (VP (VBD were)
        (VP
          (VP (VBN washed)
            (PP (IN with)
              (NP (NNS PBS))))
          (CC and)
          (VP (VBN incubated)
            (PP (IN for)
              (NP (CD 2) (NNS hours)))
            (PP (IN at)
              (NP (NN 37°C)))
            (PP (IN with)
              (NP
                (NP
                  (ADJP (CD 20) (NN μg/ml))
                  (NN Delta1-Fc))
                (CC or)
                (NP (NN hIgG4) (NN control))))
            (, ,)
            (S
              (VP (VBN washed)
                (ADVP (RB once) (RB again))
                (PP (IN with)
                  (NP (NNS PBS)))
                (, ,)
                (SBAR (IN before)
                  (S
                    (NP (NNS cells))
                    (VP (VBD were)
                      (VP (VBN plated)
                        (PP (IN for)
                          (NP (NN stimulation)))))))))))))
    (. .)))

(
  (S
    (S
      (VP (TO To)
        (VP (VB examine)
          (NP
            (NP (DT the) (NN effect))
            (PP (IN of)
              (NP
                (NP (JJ coincident) (NN Delta1-Fc))
                (CC and)
                (NP (NN T-cell) (NN receptor) (NN signalling))))
            (PP (IN on)
              (NP (JJ primary) (JJ CD4+) (NNS T-cells)))))))
    (, ,)
    (NP
      (ADJP
        (ADJP (JJ 96-))
        (CC or)
        (ADJP (JJ 24-well)))
      (NNS plates))
    (VP (VBD were)
      (ADVP (RB first))
      (VP (VBN coated)
        (ADVP (JJ overnight))
        (PP (IN at)
          (NP
            (NP (NN 4°C))
            (PP (IN with)
              (NP
                (NP
                  (NP (DT a) (NN mixture))
                  (PP (IN of)
                    (NP (NN capture) (NNS antibodies))))
                (VP (VBG consisting)
                  (PP (IN of)
                    (NP
                      (NP
                        (NP (JJ anti-mouse) (NN IgG2a))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 1) (NN μg/ml) (, ,) (NNP BD) (NNP Biosciences))
                          (-RRB- -RRB-)))
                      (CC and)
                      (NP
                        (NP (NN anti-hIgG4))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 1) (NN μg/ml) (, ,) (NNP BD) (NNP Biosciences))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Plates))
      (VP (VBD were)
        (VP
          (VP (VBN washed)
            (PP (IN with)
              (NP (NNS PBS))))
          (CC and)
          (VP (VBN incubated)
            (PP
              (NP (CD 2) (NNS hours))
              (IN at)
              (NP (NN 37°C)))
            (PP (IN with)
              (NP
                (NP (DT a) (NN mixture))
                (PP (IN of)
                  (NP
                    (NP
                      (NP (NN anti-CD3))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 3) (NN μg/ml))
                        (, ,)
                        (S
                          (NP (NN clone))
                          (NP (NNP Hit3a) (, ,) (NNP BD) (NNP Biosciences)))
                        (-RRB- -RRB-)))
                    (CC and)
                    (NP
                      (NP
                        (NP
                          (ADJP (CD 20) (NN μg/ml))
                          (NN Delta1-Fc))
                        (CC or)
                        (NP (NN hIgG4) (NN control)))
                      (PRN (-LRB- -LRB-)
                        (NP (NN Sigma))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NNS Plates))
        (VP (VBD were)
          (ADVP (RB again))
          (VP (VBN washed)
            (PP (IN with)
              (NP (NNS PBS))))))
      (CC and)
      (S
        (NP (VBN purified) (JJ CD4+) (NN T) (NNS cells))
        (VP (VBD were)
          (VP (VBN seeded)
            (PP (IN at)
              (NP (CD 2) (NN ×) (NN 105/well)))
            (PP (IN in)
              (NP
                (NP (DT the) (NN presence))
                (PP (IN of)
                  (NP
                    (NP (JJ soluble) (NN anti-CD28))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 2) (NN μg/ml))
                      (, ,)
                      (NP (NN clone) (CD CD28.2))
                      (, ,)
                      (NP (NNP BD) (NNP Bioscience))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN assay))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN described)
            (ADVP (RB previously))
            (S
              (NP (NN -LSB-20))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Briefly))
      (, ,)
      (NP
        (NP (DT a) (NN CHO) (NN cell) (NN line))
        (PRN (-LRB- -LRB-)
          (NP (NN CHO-N2))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (VP (VBN established)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBD expressed)
                (NP (CC both)
                  (NP (DT a) (JJ full-length) (JJ human) (NN Notch2) (NN cDNA))
                  (, ,)
                  (CC and)
                  (NP (NN p10xCBF1-luc)))))))))
    (. .)))

(
  (S
    (S
      (NP (CD 2) (JJ ×) (NN 104) (NN CHO-N2) (NNS cells))
      (VP (VBD were)
        (VP (VBN plated)
          (PP (IN per)
            (NP (NN well)))
          (PP (IN into)
            (NP (JJ 96-well) (NNS plates)))))
      (, ,)
      (CC and)
      (S
        (ADJP (JJ left)
          (S
            (VP (TO to)
              (VP (VB adhere)
                (PP (IN for)
                  (NP (CD 2) (NNS hours)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Notch) (NN signalling))
      (VP (VBD was)
        (VP (VBN activated)
          (PP (IN by)
            (S
              (VP (VBG plating)
                (NP
                  (NP (DT an) (JJ additional) (NN CHO) (NN line))
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (ADVP (RB stably))
                      (VP (VBZ expresses)
                        (NP
                          (NP
                            (NP (JJ full-length) (JJ human) (NN Delta1))
                            (PRN (-LRB- -LRB-)
                              (NP (NN CHO-hDelta1))
                              (-RRB- -RRB-)))
                          (PP (IN onto)
                            (NP (DT the) (JJ CHO-N2) (NNS cells))))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NNS Cells))
        (VP (VBD were)
          (VP (VBN co-cultured)
            (PP (IN in)
              (NP (DT this) (NN manner) (JJ overnight))))))
      (, ,)
      (CC and)
      (S
        (NP (NN luciferase) (NN activity))
        (VP (VBD determined)
          (SBAR (IN as)
            (S
              (VP (VBN described)))))))
    (. .)))

(
  (S
    (S
      (NP (NN RNA))
      (VP (VBD was)
        (VP (VBN isolated)
          (PP (IN from)
            (NP
              (NP (NN cell) (NNS samples))
              (VP (VBG using)
                (NP
                  (NP (NN Rneasy) (NNS kits))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Qiagen))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ First) (NN strand) (NN cDNA))
      (VP (VBD was)
        (VP (VBN synthesised)
          (PP (IN with)
            (NP
              (NP
                (NP (NN SuperScriptII) (-LRB- -LRB-) (NN Invitrogen) (-RRB- -RRB-) (NN oligo-d))
                (PRN (-LRB- -LRB-)
                  (NP (NN T))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (NP (JJ random) (NNS decamers))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Invitrogen))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Q-PCR))
      (VP (VBD was)
        (VP (VBN performed)
          (S
            (VP (VBG using)
              (NP
                (NP (NN SYBR) (NN green) (NN detection) (NN chemistry))
                (PP (IN on)
                  (NP (DT the) (NN Roche) (NN Lightcycler) (NN system)))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Gene-specific) (NN quantification))
      (VP (VBD was)
        (VP (VBN achieved)
          (PP (IN by)
            (S
              (VP (VBG comparing)
                (NP (DT each) (NN cDNA))
                (PP (TO to)
                  (NP
                    (NP (DT a) (JJ serially-diluted) (JJ standard) (NN plasmid))
                    (VP (VBG containing)
                      (NP (DT the) (JJ relevant) (NN amplicon)))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Relative) (NN Hes-1) (NN expression) (NNS levels))
      (VP (VBD were)
        (VP (VBN normalised)
          (PP (TO to)
            (NP (NN 18S) (NN rRNA) (JJ housekeeping) (NN gene))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Primer) (NNS sequences))
        (VP (VBN used)))
      (VP (VBD were)
        (PP (IN as)
          (NP
            (NP
              (NP (VBZ follows))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP
                    (NP (CD 5) ('' '))
                    (TO to) (CD 3))
                  ('' '))
                (-RRB- -RRB-))
              (: :)
              (NP
                (NP (NN 18S) (NN rRNA))
                (, ,)
                (NP (NN GTAACCCGTTGAACCCCATT))
                (CC and)
                (NP (NN CCATCCAATCGGTAGTAGCG))))
            (: ;)
            (NP
              (NP (NN Hes-1))
              (, ,)
              (NP (NN CTCTCTTCCCTCCGGACTCT))
              (CC and)
              (NP (NN GGCGCAATCCAATATGAAC)))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Authors) (POS '))
      (NNS contributions))))

(
  (S
    (S
      (NP
        (NP (NN GM))
        (CC and)
        (NP (NN GH)))
      (VP
        (VP (VBD conceived)
          (NP (DT this) (NN study)))
        (CC and)
        (VP (VBP wrote)
          (NP (DT the) (NN manuscript)))))
    (. .)))

(
  (S
    (S
      (NP (NN GM))
      (VP (VBD was)
        (ADVP (RB experimentally))
        (VP (VBN involved)
          (PP (IN in)
            (NP
              (NP
                (NP (NN CHO))
                (, ,)
                (NP (NN Jurkat))
                (CC and)
                (NP (JJ primary) (NN T-cell)))
              (NNS assays))))))
    (. .)))

(
  (S
    (S
      (NP (NN GH))
      (VP (VBD was)
        (ADVP (RB experimentally))
        (VP (VBN involved)
          (PP (IN in)
            (NP (DT the) (JJ neuronal) (NNS studies))))))
    (. .)))

(
  (S
    (S
      (NP (NN GW))
      (VP (VBD carried)
        (PRT (RP out))
        (NP
          (NP (PDT all) (DT the) (NN CHO)
            (CC and)
            (NN Jurkat) (NNS assays))
          (CC and)
          (NP
            (NP (DT the) (JJ primary) (NN T-cell) (NNS experiments))
            (VP (VBG involving)
              (NP (JJ N1-IC) (NN transfection)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN YS))
        (CC and)
        (NP (NN EB)))
      (VP (VBD carried)
        (PP (IN out)
          (NP
            (NP (DT the) (JJ primary) (NN T-cell) (NNS experiments))
            (VP (VBG involving)
              (NP (NN Delta1-Fc) (NN stimulation)))))))
    (. .)))

(
  (S
    (S
      (NP (NN SP))
      (VP (VBD was)
        (ADVP (RB experimentally))
        (VP (VBN involved)
          (PP (IN in)
            (NP (DT the) (JJ neuronal) (NNS studies))))))
    (. .)))

(
  (S
    (S
      (NP (FW AL) (, ,)
        (NP (CD BC))
        (CC and)
        (NP (CD MT)))
      (VP (VBD provided)
        (NP
          (NP (JJ susbstantial) (JJ intellectual) (NN input))
          (PP (IN into)
            (NP
              (NP (DT all) (NNS aspects))
              (PP (IN of)
                (NP (DT this) (NN study))))))))
    (. .)))

(
  (S
    (S
      (NP (DT All) (NNS authors))
      (VP
        (VP (VBN read))
        (CC and)
        (VP (JJ approved)
          (NP (DT the) (JJ final) (NN manuscript)))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure))
      (CC and)
      (NP (NN Table))
      (NP (NNS captions)))))

(
  (S
    (S
      (NP
        (NP (NN Figure) (CD 1) (: :) (NN Inhibition))
        (PP (IN of)
          (NP (DT the) (NN PI3K-Akt) (NN pathway))))
      (VP (VBZ impairs)
        (NP
          (NP (NN Notch) (NN signalling))
          (PP (IN in)
            (NP (NN Jurkat) (NNS T-cells))))))
    (. .)))

(
  (S
    (S
      (NP
        (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-))
        (NN J-N2) (NNS cells))
      (VP (VBD were)
        (VP (VBN transfected)
          (PP (IN with)
            (NP
              (NP (CD 14) (NN μg))
              (PP (IN of)
                (NP (NN p10xCBF1-luc))))))))
    (CC and)
    (S
      (NP
        (NP (CD 1) (NN μg) (NN pTK-RL))
        (, ,)
        (VP (VBN incubated)
          (S
            (ADJP (JJ overnight))))
        (, ,))
      (ADVP (RB then))
      (VP (VBN plated)
        (PP (IN onto)
          (NP
            (NP (JJ 96-well) (NNS plates))
            (VP (VBN coated)
              (PP (IN with)
                (NP (CC either)
                  (NP
                    (ADJP (CD 20) (NN μg/ml))
                    (NN hIgG4))
                  (CC or)
                  (NP
                    (ADJP (CD 20) (NN μg/ml))
                    (NN hDelta1-Fc))))
              (PP (IN along)
                (PP (IN with)
                  (NP
                    (NP (NN LY294002))
                    (PP (IN for)
                      (NP (CD 6) (NNS hours)))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ CBF1-reporter) (NN gene) (NN activity))
      (VP (VBZ is)
        (ADJP (JJ normalised)
          (PP (TO to)
            (NP (NN Renilla) (NN control)))
          (PP (IN in)
            (NP
              (NP (DT this))
              (CC and)
              (NP (DT all))
              (NP (NN luciferase) (NNS assays)))))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-))
      (NP (NN J-N2) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN plated)
            (PP (IN onto)
              (NP (CC either)
                (NP (NN hIgG4))
                (CC or)
                (NP (NN Delta1-Fc) (NN ±) (CD 10) (NN μM) (NN LY294002)))))
          (, ,)
          (CC and)
          (VP (VBN incubated)
            (PP (IN for)
              (NP (CD 8) (NNS hours)))
            (PP (IN before)
              (S
                (VP (VBG being)
                  (VP (VBN processed)
                    (PP (IN for)
                      (NP (NN Hes1) (NN mRNA) (NNS levels)))
                    (PP (IN by)
                      (NP
                        (NP (NN Q-PCR))
                        (PRN (-LRB- -LRB-)
                          (NP (NN Hes1/18) (NN rRNA))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-))
        (NN J-N2) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN transfected)
            (PP (IN with)
              (NP
                (NP (CD 10) (NN μg))
                (PP (IN of)
                  (NP
                    (NP (NN pCBF1x10-luc))
                    (, ,)
                    (NP
                      (NP (CD 4) (NN μg))
                      (PP (IN of)
                        (NP (NN Pten) (NN expression) (NN construct))))
                    (CC or)
                    (NP
                      (NP (JJ empty) (NN pcDNA3.1) (NN vector,1) (NN μg))
                      (PP (IN of)
                        (NP (NN pTK-RL)))))))))
          (, ,)
          (CC and)
          (VP (VBN treated)
            (PP (IN with)
              (NP (CC either)
                (NP
                  (ADJP (CD 20) (NN μg/ml))
                  (NN hIgG4))
                (CC or)
                (NP
                  (ADJP (CD 20) (NN μg/ml))
                  (NN hDelta1-Fc) (NN ±) (CD 10) (NN μM) (NN LY294002))))))))
    (. .)))

(
  (S
    (S
      (NP (NN CBF1-reporter) (NN activity))
      (VP (VBD was)
        (VP (VBN measured)
          (PP (IN after)
            (NP (CD 6) (NN hr))))))
    (. .)))

(
  (S
    (S
      (NP (DT All) (NNS data))
      (VP
        (VP (VBZ is)
          (VP (VBN presented)
            (PP (IN as)
              (NP (NN mean) (NN ±) (NN s.d.)))))
        (, ,)
        (CC and)
        (VP (VBZ is)
          (ADJP (JJ representative)
            (PP (IN of)
              (NP (CD three) (NN repeat) (NNS experiments)))))))
    (. .)))

(
  (S
    (S
      (NP
        (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-))
        (NN J-N2) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN transfected)
            (PP (IN with)
              (NP
                (NP (NN p10xCBF1-luc))
                (CC and)
                (NP (NN pTK-RL)))))
          (CC and)
          (VP (VBD stimulated)
            (SBAR (IN as)
              (S
                (VP (VBN described)
                  (PP (IN in)
                    (NP (NNP Fig.) (NN 1A))))))))
        (, ,)
        (SBAR
          (WHPP (IN except)
            (WHNP (WDT that)))
          (S
            (NP (NNS cells))
            (VP (VBD were)
              (VP (VBN treated)
                (PP (IN with)
                  (NP
                    (NP
                      (NP (NN Akt) (NN inhibitor) (CD SH-6))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 50) (NN μM))
                        (-RRB- -RRB-)))
                    (CC or)
                    (NP (NN DMSO) (NN vehicle))))
                (PP (IN for)
                  (NP (CD 6) (NNS hours)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 2))
      (: :)
      (NP (DT The) (NN PI3K-Akt) (NN pathway))
      (VP (VBZ regulates)
        (NP
          (NP (NN Notch-responsiveness))
          (PP (IN in)
            (NP (JJ primary) (JJ human) (JJ CD4+) (NNS T-cells))))))
    (. .)))

(
  (S
    (S
      (NP
        (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-))
        (JJ 24-well) (NN tissue) (NN culture) (NNS plates))
      (VP (VBD were)
        (VP
          (VP (VBN coated)
            (PP (IN with)
              (NP
                (NP (JJ anti-human) (NN IgG4))
                (CC and)
                (NP (JJ anti-mouse) (NN IgG2a) (NN capture) (NNS antibodies))))
            (PP (IN at)
              (NP
                (NP (CD 1) (NN μg/ml))
                (PP (IN in)
                  (NP (NNS PBS))))))
          (, ,)
          (CC and)
          (VP (VBN incubated)
            (PP (IN at)
              (NP (NN 4°C)))
            (, ,)
            (S
              (ADJP (JJ overnight)))))))
    (. .)))

(
  (S
    (NP (JJ Appropriate) (NNS stimuli))
    (VP
      (VP (VBN added) (: :)
        (NP
          (NP (NN Delta1-Fc))
          (CC or)
          (NP (NN hIgG4)))
        (PP
          (PP (IN as)
            (NP (NN control)))
          (, ,)
          (CC both)
          (PP (IN at)
            (NP
              (NP (CD 20) (NN μg/ml))
              (PP (IN in)
                (NP
                  (NP
                    (NP
                      (NP (NN PBS))
                      (CC and)
                      (NP (NN anti-CD3)))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NNP Hit3a))
                        (, ,)
                        (NP (NN IgG2a)))
                      (-RRB- -RRB-)))
                  (CC or)
                  (NP (NN mIgG))))))
          (PP (IN as)
            (NP (NN control)))
          (, ,)
          (CC both)
          (PP (IN at)
            (NP
              (NP (CD 1) (NN μg/ml))
              (PP (IN in)
                (NP (NNS PBS)))))))
      (, ,)
      (CC and)
      (VP (VBN incubated)
        (PP (IN at)
          (NP
            (QP (CD 37°C) (, ,) (CD 3))
            (NN h)))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NNS Plates))
        (VP (VBD were)
          (VP (VBN washed)
            (PP (IN with)
              (NP (NNS PBS))))))
      (CC and)
      (S
        (NP
          (ADJP (RB positively) (VBN selected))
          (JJ hCD4+) (NNS T-cells))
        (VP (VBD were)
          (VP (VBN seeded)
            (PP (IN at)
              (NP
                (QP (CD 2) (NN ×) (CD 106))
                (NN cells/well)))
            (, ,)
            (PP (IN in)
              (NP
                (NP (CD 1) (NN ml))
                (PP (IN of)
                  (NP
                    (NP (NNS media))
                    (PP (TO to)
                      (NP
                        (NP (DT a) (NN total))
                        (PP (IN of)
                          (NP (CD 1) (NN ×) (CD 107) (NN cells/stimulation)))))))))))))
    (. .)))

(
  (S
    (NP (NNS Cells))
    (VP (VBD were)
      (VP (VBN stimulated)
        (S
          (ADJP (JJ overnight)
            (PP (VBG ±)
              (NP
                (NP
                  (NP
                    (ADJP (CD 10) (NN μM))
                    (NN DAPT))
                  (CC or)
                  (NP
                    (ADJP (CD 10) (NN μM))
                    (NN LY294002)))
                (CC and)
                (NP
                  (NP (CD 2) (NN μg/ml) (NN anti-CD28))
                  (SBAR
                    (WHADVP (WRB where))
                    (S
                      (VP (VBP applicable)))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (ADJP
          (ADJP (JJ pooled))
          (, ,)
          (ADJP
            (NP (NN RNA))
            (VBN prepared))
          (CC and)
          (ADJP
            (NP (NN cDNA))
            (VBN synthesised)))
        (SBAR (IN as)
          (S
            (VP (VBN described)
              (PP (IN in)
                (NP (NNS Methods))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Relative) (NN Hes1) (NN expression))
      (VP (VBD was)
        (VP (VBN determined)
          (PP (IN by)
            (NP (NN Q-PCR))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Data))
      (VP (VBN shown)
        (S
          (VP
            (VP (VBZ represents)
              (NP
                (NP (JJ triplicate) (NNS assays))
                (PP (IN of)
                  (NP
                    (NP (NN cDNA))
                    (VP (VBN prepared)
                      (PP (IN from)
                        (NP (JJ pooled) (NNS cells))))))))
            (, ,)
            (CC and)
            (VP (VBZ is)
              (NP
                (NP (NN representative))
                (PP (IN of)
                  (NP
                    (NP (CD two) (JJ individual) (NNS experiments))
                    (VP (VBN performed)
                      (S
                        (VP (VBG using)
                          (NP
                            (NP (JJ CD4+) (NNS T-cells))
                            (VP (VBN prepared)
                              (PP (IN from)
                                (NP
                                  (NP (JJ different) (NN donors.))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NN B))
                                    (-RRB- -RRB-)))))))))))))))))))

(
  (S
    (S
      (NP (JJ Human) (JJ primary) (JJ CD4+) (NNS T-cells))
      (VP (VBD were)
        (VP (VBN nucleofected)
          (PP (IN with)
            (NP
              (NP
                (ADJP (CD 4) (NN μg))
                (NN p10xCBF-luc))
              (, ,)
              (NP
                (NP
                  (NP
                    (ADJP (CD 0.5) (NN μg))
                    (NN pTK-RL))
                  (CC and)
                  (NP (CD 1) (NN μg)))
                (PP (IN of)
                  (NP (DT either)
                    (ADJP
                      (ADJP (JJ pN1-IC))
                      (CC or)
                      (ADJP (JJ empty)))
                    (NN pcDNA3.1))))
              (, ,)
              (CC and)
              (NP
                (NP (CD 2) (NN μg))
                (PP (IN of)
                  (NP (DT either)
                    (NP
                      (NP (NN gagAkt))
                      (CC or)
                      (NP
                        (NP (NN kinase-dead))
                        (PRN (-LRB- -LRB-)
                          (NP (NN KD))
                          (-RRB- -RRB-))))
                    (NN Akt) (NN construct)))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ CBF1-reporter) (NN activity))
      (VP (VBZ is)
        (VP (VBN presented)
          (PP (IN as)
            (NP (NN mean) (JJ normalised) (NN luminescence) (NN ±) (NN s.d.))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Data) (NN representative))
      (PP (IN of)
        (NP (CD two) (NN repeat) (NNS experiments)))
      (PP (IN from)
        (NP (JJ different) (NN blood) (NNS donors)))
      (. .))))

(
  (S
    (NP
      (NP (NN Figure) (CD 3))
      (: :)
      (S
        (NP
          (NP (NN Inhibiting) (NN GSK3β))
          (PP (IN with)
            (NP (NN lithium) (NN chloride))))
        (VP (VBZ enhances)
          (NP (NN Notch) (NNS signals))
          (PP (IN in)
            (NP (JJ primary) (JJ human)
              (UCP
                (ADJP (JJ CD4+))
                (, ,)
                (CONJP (CC but)
                  (RB not))
                (NP (NN Jurkat))
                (, ,))
              (NNS T-cells)))))
      (. .))))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-))
      (NP (JJ Primary) (JJ human) (JJ CD4+) (NNS T-cells))
      (VP (VBD were)
        (VP
          (VP (VBN nucleofected)
            (PP (IN with)
              (NP
                (NP
                  (NP
                    (ADJP (CD 4) (NN μg))
                    (NN p10xCBF-luc))
                  (, ,)
                  (NP
                    (ADJP (CD 0.5) (NN μg))
                    (NN pTK-RL))
                  (CC and)
                  (NP (CD 1) (NN μg)))
                (PP (IN of)
                  (NP (CC either)
                    (NP (NN pN1-IC))
                    (CC or)
                    (NP (NN pcDNA3.1)))))))
          (CC and)
          (VP (VBN plated)
            (NP
              (NP (NN o/n))
              (PP (IN in)
                (NP (NN triplicate)))
              (PP (IN with)
                (NP
                  (NP (VBG increasing) (NNS concentrations))
                  (PP (IN of)
                    (NP (NN LiCl))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Data))
      (VP (VBZ is)
        (VP (VBN presented)
          (PP (IN as)
            (NP
              (NP (DT the) (JJ fold) (NN induction))
              (PP (IN in)
                (NP (CD normalised) (NN luminescence)))))
          (PP (VBN compared)
            (PP (TO to)
              (NP (DT the) (JJ untreated) (NN vector) (JJ only) (NN control)))))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-))
      (NP (JJ Primary) (JJ human) (JJ CD4+) (NNS T-cells))
      (VP (VBD were)
        (VP
          (VP (VBN nucleofected)
            (PP (IN with)
              (NP (CD 4) (NN μg) (NN p10xCBF-luc))))
          (CC and)
          (VP (VBN exposed)
            (PP (TO to)
              (NP
                (NP (JJ different) (NNS levels))
                (PP (IN of)
                  (NP (JJ plate-bound) (NN Delta1-Fc)))
                (PP (IN in)
                  (NP
                    (NP (DT the)
                      (NP (NN presence))
                      (CC or)
                      (NP (NN absence)))
                    (PP (IN of)
                      (NP
                        (NP (NN LiCl))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 10) (NN mM))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-))
        (NN J-N2) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN transfected)
            (PP (IN with)
              (NP
                (NP (NN p10xCBF1-luc))
                (CC and)
                (NP (NN pTK-RL)))))
          (CC and)
          (VP (VBN stimulated)
            (PP (JJ overnight) (IN in)
              (NP
                (NP (VBG increasing) (NNS concentrations))
                (PP (IN of)
                  (NP (NN LiCl)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Data))
      (VP (VBZ is)
        (VP (VBN presented)
          (PP (IN as)
            (NP
              (NP (DT the) (JJ fold) (NN induction))
              (PP (IN in)
                (NP (CD normalised) (NN luminescence)))))
          (PP (VBN compared)
            (PP (TO to)
              (NP (DT the) (JJ untreated) (NN IgG4) (NN control)))))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 4))
      (: :)
      (NP (DT The) (NN PI3k/GSK3β) (NN pathway))
      (ADVP (RB also))
      (VP (VBZ regulates)
        (NP
          (NP (NN Notch) (NN signalling))
          (PP
            (PP (IN in)
              (NP (NN CHO) (NNS cells)))
            (CC and)
            (PP (IN in)
              (NP (JJ primary) (NNS neurons)))))))
    (. .)))

(
  (S
    (S
      (NP
        (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-))
        (NN CHO-N2) (NNS cells))
      (VP (VBD were)
        (VP (VBN co-cultured)
          (PP (IN with)
            (NP
              (NP
                (NP
                  (NP (VBG increasing) (NNS numbers))
                  (PP (IN of)
                    (NP (CC either)
                      (NP (NN CHO-hDelta1))
                      (CC or)
                      (NP (NN control) (NN CHO) (NNS cells)))))
                (CC and)
                (NP (NN luciferase) (NN reporter) (NN activity)))
              (VP (VBN assayed)
                (PP (IN for))
                (PP (IN after)
                  (NP (CD 24) (NNS hours)))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ CBF1-dependent) (NN reporter) (NN activity))
      (VP (VBZ is)
        (VP (VBN presented)
          (PP (IN as)
            (NP
              (NP (DT the) (JJ fold) (NN induction))
              (PP (IN in)
                (NP
                  (NP (NN luminescence))
                  (CC versus)
                  (NP (NN CHO-N2) (NN cell) (JJ only) (NN value)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Mean) (NN ±) (NN sem))
      (VP (VBN given)))
    (. .)))

(
  (S
    (S
      (NP
        (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-))
        (NN CHO-N2) (NNS cells))
      (VP (VBD were)
        (VP (VBN co-cultured)
          (PP (IN with)
            (NP
              (NP (NN 104) (NN CHO-hDelta1) (NNS cells))
              (PP (IN per)
                (NP
                  (ADJP (RB well) (VBN ±))
                  (NN insulin) (NN ±) (NN LY294002)))))
          (SBAR (IN as)
            (S
              (VP (VBN indicated)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ CBF1-reporter) (NN activity))
      (VP (VBZ is)
        (VP (VBN presented)
          (PP (IN as)
            (NP
              (NP (JJ fold) (NN induction))
              (PP (IN of)
                (NP (JJ non-insulin) (JJ stimulated) (NNS cells))))))))
    (. .)))

(
  (S
    (S
      (NP
        (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-))
        (NN CHO-N2) (NNS cells))
      (VP (VBD were)
        (VP (VBN co-cultured)
          (PP (IN with)
            (S
              (VP (VBG increasing)
                (NP
                  (NP (NNS numbers))
                  (PP (IN of)
                    (NP (NN CHO-hDelta1))))
                (PP (IN in)
                  (NP
                    (NP (DT the)
                      (NP (NN presence))
                      (CC or)
                      (NP (NN absence)))
                    (PP (IN of)
                      (NP
                        (NP (NN LiCl))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 10) (NN mM))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-))
      (NP (NN Rat) (JJ primary) (JJ hippocampal) (NNS neurons))
      (VP (VBD were)
        (VP (VBN transfected)
          (PP (IN with)
            (NP
              (NP (CD 0.5) (NN μg))
              (PP (IN of)
                (NP
                  (NP (NN p10xCBF1-luc))
                  (CC and)
                  (NP
                    (ADJP (CD 0.05) (NN μg))
                    (NN pTK-RL))))
              (, ,)
              (VP
                (ADVP (RB then))
                (VBN stimulated)
                (S
                  (ADJP (JJ overnight)
                    (PP (IN with)
                      (NP (CC either)
                        (NP (NN LiCl))
                        (CC or)
                        (NP
                          (ADJP (CD 25) (NN ng/ml))
                          (NN BDNF) (NN ±) (CD 10) (NN μM) (NN LY294002))))))))))))
    (. .)))

(
  (S
    (S
      (NP (-LRB- -LRB-) (NN E) (-RRB- -RRB-) (NNS Neurons))
      (VP (VBD were)
        (VP (VBN transfected)
          (PP (IN with)
            (NP
              (NP (CD 0.2) (NN μg))
              (PP (IN of)
                (NP
                  (NP (NN p10xCBF1-luc))
                  (, ,)
                  (NP
                    (ADJP (CD 0.05) (NN μg))
                    (NN pTK-RL))
                  (, ,)
                  (NP
                    (NP (CD 0.05) (NN μg))
                    (PP (IN of)
                      (NP (NN pN1-IC))))
                  (CC and)
                  (NP
                    (NP (CD 0.4) (NN μg))
                    (PP (IN of)
                      (NP (DT the) (JJ relevant) (NN expression) (NN plasmid)))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN CBF1-reporter) (NN activity))
      (VP (VBZ is)
        (VP (VBN presented)
          (PP (IN as)
            (NP
              (NP (JJ normalised) (NN luminescence) (NN ±) (NN s.e.m))
              (PRN (-LRB- -LRB-)
                (NP (NN n) (JJ =) (CD 3))
                (-RRB- -RRB-))))))
      (. .))
    (PRN (-LRB- -LRB-)
      (NP
        (NP (NNP *))
        (NP (NN p))))))

(
  (S
    (S
      (PRN
        (NP (NN <) (CD 0.05))
        (, ,)
        (NP (NNP Mann) (NNP Whitney) (NNP U) (NN test))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 5))
      (: :)
      (S
        (NP
          (NP (DT A) (NN schematic))
          (VP (VBG depicting)
            (NP
              (NP (DT a) (JJ proposed) (NN mechanism))
              (PP (IN for)
                (NP
                  (NP (DT the) (NN influence))
                  (PP (IN of)
                    (NP (DT the) (NN PI3K) (NN pathway)))
                  (PP (IN on)
                    (NP (NN Notch-responsiveness.))))))))
        (VP (VB See)
          (NP (NNS text))
          (PP (IN for)
            (NP
              (NP (NN discussion))
              (PP (IN of)
                (NP (DT this) (NN model)))))))
      (. .))))

